Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Pediatric Cancer,2016,NINDS,4R01NS073870-06,,Defining the role of BRAF in glioma initiation and maintenance,"HOLMEN, SHERI",UNIVERSITY OF UTAH,UT,"$325,938"
Pediatric Cancer,2016,NINDS,4U01NS082328-03,,Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma,"ABOODY, KAREN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$1,238,896"
Pediatric Cancer,2016,NCI,1K22CA197074-01,,Exosomic microRNAs and drug resistance in AML tumor microenvironment,"CHALLAGUNDLA, KISHORE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$154,958"
Pediatric Cancer,2016,NCI,4R01CA072669-19,,Cytotoxic-T-Lymphocyte (CTL) Therapy of AML,"BLAZAR, BRUCE",UNIVERSITY OF MINNESOTA,MN,"$294,076"
Pediatric Cancer,2016,NCI,5R01CA132640-15,,Role of heat shock factors (Hsfs) in tumorigenesis,"MIVECHI, NAHID",GEORGIA REGENTS UNIVERSITY,GA,"$270,000"
Pediatric Cancer,2016,NCI,4U24CA055727-22,,Childhood Cancer Survivor Study,"ARMSTRONG, GREGORY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$4,172,004"
Pediatric Cancer,2016,NCI,5R01CA190964-02,,Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia,"VAN ETTEN, RICHARD",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$544,106"
Pediatric Cancer,2016,NHLBI,5K08HL118367-03,,ELUCIDATING THE ROLE OF KRUPPEL LIKE FACTOR 7 IN T CELL DEVELOPMENT,"SCHUETTPELZ, LAURA",WASHINGTON UNIVERSITY,MO,"$26,438"
Pediatric Cancer,2016,NCI,4P30CA006516-51,6056,Neuro-Oncology,"MARTUZA, ROBERT",MASSACHUSETTS GENERAL HOSPITAL,MA,"$93,279"
Pediatric Cancer,2016,NCI,5R01CA090668-13,,FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia,"SMALL, DONALD",JOHNS HOPKINS UNIVERSITY,MD,"$291,600"
Pediatric Cancer,2016,NHLBI,5F32HL124948-02,,Characterization of Calmodulin and CHK2 inhibitors for the treatment of Diamond B,"MACARI, ELIZABETH",CHILDREN'S HOSPITAL CORPORATION,MA,"$58,002"
Pediatric Cancer,2016,NCI,5R03CA182063-03,,Persistent SIX2 expression as a first hit mechanism in Wilms tumorigenesis,"LOVVORN, HAROLD",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$79,000"
Pediatric Cancer,2016,NCI,5R21CA191544-02,,CendR peptide-mediated enhancement of systemic oncolytic herpes virotherapy,"CRIPE, TIMOTHY",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$195,098"
Pediatric Cancer,2016,NHLBI,4R01HL111103-05,,Identification and characterization of genes in del(5q) myelodysplastic syndrome,"STARCZYNOWSKI, DANIEL",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$382,500"
Pediatric Cancer,2016,NCI,7R21CA192003-02,,Deciphering the pathogenesis of pediatric high-grade gliomas,"LI, GUO-MIN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$194,290"
Pediatric Cancer,2016,NCI,4R01CA158006-05,,Ikaros-based epigenetic regulation of T cell leukemogenesis,"GEORGOPOULOS, KATIA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$342,218"
Pediatric Cancer,2016,NCI,4R01CA157838-05,,Longitudinal Cardiotoxicity in Adult Survivors Childhood Cancer,"ARMSTRONG, GREGORY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$536,801"
Pediatric Cancer,2016,NCI,5R01CA182528-04,,Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia,"CHEN, JIANJUN",UNIVERSITY OF CINCINNATI,OH,"$336,114"
Pediatric Cancer,2016,NICHD,4R01HD062484-06,,Pharmacogenetic Determinants of Vincristine Toxicity and Response,"RENBARGER, JAMIE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$614,577"
Pediatric Cancer,2016,NCI,4R01CA118332-09,,Parent-Child Communication About Cancer,"COMPAS, BRUCE",VANDERBILT UNIVERSITY,TN,"$393,884"
Pediatric Cancer,2016,NCI,4R01CA167708-04,,Targeting AML with PI3K/AKT inhibitors and BH3-mimetics,"GRANT, STEVEN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$284,794"
Pediatric Cancer,2016,NCI,5R01CA190617-02,,Itraconazole Analogues to Treat Medulloblastoma,"HADDEN, MATTHEW",UNIVERSITY OF CONNECTICUT STORRS,CT,"$367,973"
Pediatric Cancer,2016,NCI,5P30CA008748-50,7572,Research Pharmacy,"MULLER, RAYMOND",SLOAN-KETTERING INST CAN RESEARCH,NY,"$206,350"
Pediatric Cancer,2016,NCI,5R01CA191077-02,,Assay Development for NSD1 Methyltransferase Inhibitor Discovery,"NAPPER, ANDREW",ALFRED I. DU PONT HOSP FOR CHILDREN,DE,"$312,244"
Pediatric Cancer,2016,NCI,5R01CA185301-02,,Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention,"CALIGIURI, MICHAEL",OHIO STATE UNIVERSITY,OH,"$352,275"
Pediatric Cancer,2016,NCI,5R01CA178380-03,,Leukotriene-Induced Nestin Expression Promotes Medulloblastoma Tumorigenesis,"YANG, ZENG-JIE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$370,388"
Pediatric Cancer,2016,NCI,5K08CA181340-03,,Targeting Chromatin Modifications in Leukemia with Trisomy 21,"LANE, ANDREW",DANA-FARBER CANCER INST,MA,"$155,991"
Pediatric Cancer,2016,NCI,5F30CA183507-03,,Cytotoxicity of MLN4924 in Acute Myeloid Leukemia,"KNORR, KATHERINE",MAYO CLINIC ROCHESTER,MN,"$42,276"
Pediatric Cancer,2016,NCI,5R01CA142928-07,,Targeting the Kinome in Neurofibromatosis type 1,"CHERNOFF, JONATHAN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$423,938"
Pediatric Cancer,2016,NCI,5R21CA185036-02,,Identification and Targeting Therapy Resistant Osteosarcoma,"MAKI, CARL",RUSH UNIVERSITY MEDICAL CENTER,IL,"$167,987"
Pediatric Cancer,2016,NCI,4R01CA173636-04,,Role of TET2 mutations in malignant transformation and acute myeloid leukemia,"LEVINE, ROSS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$639,626"
Pediatric Cancer,2016,NHLBI,5R01HL117976-03,,Epithelial mechanisms of inducible resistance to AML-associated pneumonia,"EVANS, SCOTT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$400,000"
Pediatric Cancer,2016,NIAID,4R01AI018757-34,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$412,500"
Pediatric Cancer,2016,NCI,5K07CA174728-03,,A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors,"DEVINE, KATIE",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$164,851"
Pediatric Cancer,2016,NINDS,5R21NS092001-02,,In Vivo Analysis of TrkB Signaling During Sympathetic Nervous System Development and Neuroblastoma Pathogenesis,"KULESA, PAUL",STOWERS INSTITUTE FOR MEDICAL RESEARCH,MO,"$206,250"
Pediatric Cancer,2016,NCI,5R01CA137060-08,,PRE-B CELL RECEPTOR SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA,"MUSCHEN, MARKUS","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$356,625"
Pediatric Cancer,2016,NCI,4R37CA072614-20,,Translational Investigation of KRas & NF1 in Myeloid Leukemia,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$304,773"
Pediatric Cancer,2016,NCI,4R01CA172398-04,,The role of ETV6 in T-cell acute lymphoblastic leukemia,"FERRANDO, ADOLFO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Pediatric Cancer,2016,NCI,4R01CA160433-05,,The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission),"ARMANIOS, MARY",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Pediatric Cancer,2016,NCI,5R00CA178207-04,,Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,"BENAVENTE ARIAS, CLAUDIA",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$246,582"
Pediatric Cancer,2016,NCI,5F30CA183269-03,,Exosomal MicroRNA as a Driver of Immune Evasion in AML,"HORNICK, NOAH",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$42,732"
Pediatric Cancer,2016,NCI,2P30CA016520-40,7999,Clinical Protocol and Data Management (Core 012),"VOGL, DAN",UNIVERSITY OF PENNSYLVANIA,PA,"$1,045,017"
Pediatric Cancer,2016,NCI,2P30CA016520-40,8007,Hematologic Malignancies Research Program,"STADTMAUER, EDWARD",UNIVERSITY OF PENNSYLVANIA,PA,"$72,887"
Pediatric Cancer,2016,NCI,2P30CA016520-40,8009,Pediatric Oncology Research Program,"BRODEUR, GARRETT",UNIVERSITY OF PENNSYLVANIA,PA,"$70,898"
Pediatric Cancer,2016,NCI,5R33CA191143-02,,Single cell growth assay for residual cells in acute lymphoblastic leukemia,"MANALIS, SCOTT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$366,536"
Pediatric Cancer,2016,NCI,2P30CA014089-41,8290,Tumor Microenvironment Research Program (Project-003),"DECLERCK, YVES",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$35,512"
Pediatric Cancer,2016,NCI,2P30CA062203-19,8736,Clinical Protocol and Data Management (CPDM),"O'BRIEN, SUSAN",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$233,836"
Pediatric Cancer,2016,NCI,2P30CA016058-40,5094,Clinical Protocol and Data Management (Core 017),"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$376,607"
Pediatric Cancer,2016,NCI,5F30CA183276-03,,Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis,"PEDERSEN, ELISABETH",UNIVERSITY OF MICHIGAN,MI,"$34,015"
Pediatric Cancer,2016,NCI,5F31CA183529-03,,Targeting aerobic glycolysis in T-ALL,"KISHTON, RIGEL",DUKE UNIVERSITY,NC,"$17,159"
Pediatric Cancer,2016,NCI,4P30CA046934-28,8118,STAFF INVESTIGATORS,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$56,573"
Pediatric Cancer,2016,NCI,4P30CA046934-28,8122,PREVENTION-CONTROL,"MARCUS, AL",AMC CANCER RESEARCH CENTER,CO,"$36,905"
Pediatric Cancer,2016,NCI,4R01CA172268-04,,The role of inhibitory receptors in leukemia development,"ZHANG, CHENGCHENG",UT SOUTHWESTERN MEDICAL CENTER,TX,"$329,925"
Pediatric Cancer,2016,NCI,4R01CA172387-04,,Polysomy 21 in Acute Lymphoblastic Leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$352,946"
Pediatric Cancer,2016,NHLBI,1R01HL130034-01,,The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML,"FRIEDMAN, ALAN",JOHNS HOPKINS UNIVERSITY,MD,"$405,000"
Pediatric Cancer,2016,NIGMS,2SC1GM093999-07,,Molecular Analysis of RECQ1 Functions in Genome Maintenance,"SHARMA, SUDHA",HOWARD UNIVERSITY,DC,"$327,000"
Pediatric Cancer,2016,NIAID,4U01AI104342-04,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Pediatric Cancer,2016,NCI,4P01CA094237-14,7520,VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,517"
Pediatric Cancer,2016,NCI,4P01CA094237-14,7530,CHIMERIC T CELLS TARGETING NEUROBLASTOMA,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,508"
Pediatric Cancer,2016,NHLBI,5R01HL117737-17,,Microchimerism as AlloImmunity,"NELSON, J.",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$477,844"
Pediatric Cancer,2016,NHLBI,1R01HL131444-01,,The role of EVI1-induced hypermethylation in leukemogenesis.,"QIAN, ZHIJIAN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$399,708"
Pediatric Cancer,2016,NICHD,1R01HD086195-01,,Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors,"LI, YUANPEI",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$311,049"
Pediatric Cancer,2016,NCI,1R01CA201184-01,,Biologic and Therapeutic Significance of miR-155 in AML,"MARCUCCI, GUIDO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$574,050"
Pediatric Cancer,2016,NCI,1K07CA200668-01,,Patient Preferences and Adherence in Adolescents and Young Adults with Cancer,"MCGRADY, MEGHAN",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$144,855"
Pediatric Cancer,2016,NINDS,5R01NS088219-02,,Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis,"GERSHON, TIMOTHY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$327,837"
Pediatric Cancer,2016,NCI,5R01CA190843-02,,"A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia","SOHN, LYDIA",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$311,458"
Pediatric Cancer,2016,NCI,1K22CA201103-01,,Targeting nutrient-sensing pathways in cancer,"LAZARUS, MICHAEL",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$190,640"
Pediatric Cancer,2016,NCI,4R01CA164024-04,,Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML,"HORTON, TERZAH",BAYLOR COLLEGE OF MEDICINE,TX,"$309,159"
Pediatric Cancer,2016,NCI,5R21CA185799-02,,Exploring the oncogenic potential of human APOBEC3 cytosine deaminases,"WEITZMAN, MATTHEW",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$219,240"
Pediatric Cancer,2016,NCI,5R01CA192924-02,,CSF2 receptor mediated actions in t(8;21) leukemia,"ZHANG, DONG-ER",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$344,868"
Pediatric Cancer,2016,NCI,1R21CA187548-01A1,,Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma,"BARANOWSKA-KORTYLEWICZ, JANINA",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$196,403"
Pediatric Cancer,2016,NCI,5R21CA183623-02,,Pediatric Cancer Salvia Biorepository,"GRAHAM, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$251,676"
Pediatric Cancer,2016,NCI,5R01CA194057-02,,Metabolic pathways in leukemia,"SCHUETZ, JOHN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$409,749"
Pediatric Cancer,2016,NCI,5R01CA183874-02,,Mechanism of tumor promotion by the H3K9 histone demethylase KDM3A in Ewing Sarcoma.,"JEDLICKA, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$355,706"
Pediatric Cancer,2016,NCI,1R03CA201540-01,,Cognitive and Psychosocial Functioning of Children Treated for Retinoblastoma,"WILLARD, VICTORIA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$89,312"
Pediatric Cancer,2016,NCI,5F30CA186466-02,,Role of GSK3beta Subcellular Localization in AML Stemness,"IGNATZ-HOOVER, JAMES",CASE WESTERN RESERVE UNIVERSITY,OH,"$28,572"
Pediatric Cancer,2016,NCI,5F31CA192558-02,,Epigenetic Regulation of Neuroblast Differentiation,"GAVIGLIO, ANGELA",DUKE UNIVERSITY,NC,"$26,208"
Pediatric Cancer,2016,NIDCR,5K99DE023826-02,,Hedgehog Pathway Activity and Targeting in KCOT,"AMM, HOPE",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$123,378"
Pediatric Cancer,2016,NIDDK,5R01DK105014-02,,Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes,"HUANG, GANG",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$351,000"
Pediatric Cancer,2016,NCI,4R01CA132685-09,,Molecular Mechanisms Regulating the Retinoblastoma Protein Family,"RUBIN, SETH",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$290,171"
Pediatric Cancer,2016,NCI,5R01CA193235-02,,Metabolic Regulation in Leukemia-Initatiating Cells,"NAKADA, DAISUKE",BAYLOR COLLEGE OF MEDICINE,TX,"$462,191"
Pediatric Cancer,2016,NIGMS,4R01GM103999-04,,Mouse Models of Functional Insertion Polymorphisms,"BURNS, KATHLEEN",JOHNS HOPKINS UNIVERSITY,MD,"$307,800"
Pediatric Cancer,2016,NICHD,5R01HD079568-02,,MICROBLEEDS AS A MARKER OF RADIATION-INDUCED BRAIN INJURY IN PEDIATRIC PATIENTS,"LUPO, JANINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$493,296"
Pediatric Cancer,2016,NCI,2R01CA080728-16A1,,Dissection of eIF4E dependent mRNA export,"BORDEN, KATHERINE",UNIVERSITY OF MONTREAL,CANADA,"$210,799"
Pediatric Cancer,2016,NCI,4R01CA172392-04,,Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion,"CASTELLINO, ROBERT",EMORY UNIVERSITY,GA,"$323,700"
Pediatric Cancer,2016,NCI,5R01CA174683-03,,Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia,"BHATIA, SMITA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$620,968"
Pediatric Cancer,2016,NCI,1R03CA201953-01,,Adolescent tanning and social media,"MORENO, MEGAN",SEATTLE CHILDREN'S HOSPITAL,WA,"$75,000"
Pediatric Cancer,2016,NCI,1R21CA194829-01A1,,Metabolic regulation of T-ALL cellular proliferation and lifespan,"RATHMELL, JEFFREY",VANDERBILT UNIVERSITY,TN,"$18,375"
Pediatric Cancer,2016,NCI,4R01CA160593-04,,Survival Bump Hunting for Finding Informative Subgroups in High Dimensional Data.,"RAO, J",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$261,828"
Pediatric Cancer,2016,NCI,5R01CA185687-02,,Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging,"SMITH-BINDMAN, REBECCA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$2,196,358"
Pediatric Cancer,2016,NCI,1R21CA202210-01,,Symptom progress and adverse health outcomes in adult childhood cancer survivors,"HUANG, I-CHAN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$233,106"
Pediatric Cancer,2016,NCI,4R01CA160872-05,,Discovery and Optimization of AML Prognostic Biomarkers,"STIREWALT, DEREK",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$458,821"
Pediatric Cancer,2016,NCI,4R01CA160256-05,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Pediatric Cancer,2016,NCI,4R01CA172040-04,,Microenvironment-Leukemia Communication Through Lectins,"HEISTERKAMP, NORA",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$336,150"
Pediatric Cancer,2016,NCI,5R01CA188520-02,,"Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy","BHASKARA, SRIVIDYA",UNIVERSITY OF UTAH,UT,"$340,838"
Pediatric Cancer,2016,NCI,1R21CA191818-01A1,,Proton minibeams: Overcoming proton beamsÂ’ inability to spare superficial tissues,"KRISHNAN, SUNIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$235,488"
Pediatric Cancer,2016,NCI,1R01CA195732-01A1,,The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy,"LICHT, JONATHAN",UNIVERSITY OF FLORIDA,FL,"$343,125"
Pediatric Cancer,2016,NCI,1R21CA191989-01A1,,Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation,"DANHAUER, SUZANNE",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$202,275"
Pediatric Cancer,2016,NCI,5U10CA180899-03,,Children's Oncology Group Statistics and Data Center,"DEVIDAS, MEENAKSHI",UNIVERSITY OF FLORIDA,FL,"$8,167,603"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6700,Cancer Prevention & Control,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$586,947"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6701,Developmental Biology and Solid Tumor,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$984,904"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6702,Hematalogical Malignancies,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$693,252"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6703,Neurobiology and Brain Tumors,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$324,910"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6704,Shared Resource Group1: Genomics and Statistics,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$188,256"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6707,Data and Safety Monitoring/NIH Policy,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$152,691"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6708,Protocol Review and Monitoring System,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$254,438"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6709,Early Phase Clinical Research Support,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$255,476"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6710,Senior Leadership,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$370,919"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6711,Planning and Evaluation,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$75,012"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6713,Administration,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$257,436"
Pediatric Cancer,2016,NCI,5P30CA021765-37,6716,Transdisciplinary Collaboration and Coordination,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$318,644"
Pediatric Cancer,2016,NCI,5R01CA169784-03,,Genetic Dissection of Acute Myeloid Leukemia.,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$355,993"
Pediatric Cancer,2016,NCI,5R01CA129541-11,,An investigation of Radial Glia as the source of Ependymoma Stem Cells,"GILBERTSON, RICHARD",UNIVERSITY OF CAMBRIDGE,UK,"$199,044"
Pediatric Cancer,2016,NCI,5U10CA180884-03,,COG NCTN Solid Malignancy Integrated Translational Science Center,"ADAMSON, PETER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$400,000"
Pediatric Cancer,2016,NCI,1R01CA187219-01A1,,Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas,"POLLACK, IAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$357,496"
Pediatric Cancer,2016,NCI,5R01CA166429-05,,Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia,"STEIDL, ULRICH","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$384,342"
Pediatric Cancer,2016,NCI,4R01CA174793-04,,BET bromodomain inhibition as targeted therapy in acute myeloid leukemia,"VAKOC, CHRISTOPHER",COLD SPRING HARBOR LABORATORY,NY,"$557,762"
Pediatric Cancer,2016,NCI,2R01CA142665-06,,Glucocorticoids in Lymphoblastic Leukemia,"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$485,955"
Pediatric Cancer,2016,NCI,2R01CA142874-06A1,,Targeting PML for Leukemia Therapy,"PANDOLFI, PIER PAOLO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$465,791"
Pediatric Cancer,2016,NCI,1R01CA193677-01A1,,Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma,"SCACHERI, PETER",CASE WESTERN RESERVE UNIVERSITY,OH,"$362,569"
Pediatric Cancer,2016,NCI,1R01CA194058-01A1,,Painted erythrocyte carriers for therapy of acute myeloid leukemia,"SIMBERG, DIMITRI",UNIVERSITY OF COLORADO DENVER,CO,"$352,151"
Pediatric Cancer,2016,NICHD,1R01HD083930-01A1,,Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation,"ZELINSKI, MARY",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$605,663"
Pediatric Cancer,2016,NCI,5R01CA166559-05,,Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors,"LANDIER, WENDY",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$674,412"
Pediatric Cancer,2016,NICHD,5R21HD081319-02,,Combination strategies to enhance therapy for Ph-like B-ALL,"FRUMAN, DAVID",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$201,951"
Pediatric Cancer,2016,NCI,4R01CA166770-05,,Characterization of a T cell dysfunctional state induced in mice with AML,"KLINE, JUSTIN",UNIVERSITY OF CHICAGO,IL,"$327,850"
Pediatric Cancer,2016,NCI,5U10CA180866-03,,Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.,"LEVINE, ELLIS",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$616,000"
Pediatric Cancer,2016,NCI,5R21CA181417-02,,Molecular determinants of PARP inhibitor sensitivity in 11q-deleted malignancy,"FRANCO, SONIA",JOHNS HOPKINS UNIVERSITY,MD,"$219,957"
Pediatric Cancer,2016,OD,4K01OD010554-06,,Loss of EBF1 Expression:  A Novel Murine Model for Human B-ALL,"RAMIREZ, JULITA",UNIVERSITY OF WASHINGTON,WA,"$78,062"
Pediatric Cancer,2016,NCI,5R01CA178454-04,,The role and functional mechanism of TET1 in MLL-rearranged leukemia,"CHEN, JIANJUN",UNIVERSITY OF CINCINNATI,OH,"$327,850"
Pediatric Cancer,2016,NCI,5R01CA180692-02,,Role of LMO1 in Neuroblastoma Initiation and Maintenance,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$606,838"
Pediatric Cancer,2016,NCI,5U10CA180886-03,,COG NCTN Network Group Operations Center,"ADAMSON, PETER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$21,084,883"
Pediatric Cancer,2016,NCI,5R01CA195642-02,,Triad1 regulates myelopoiesis and functions as a leukemia suppressor,"EKLUND, ELIZABETH",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$353,419"
Pediatric Cancer,2016,NHLBI,5K08HL127269-02,,Bone Marrow Microenvironmental Expression of Cytochrome P450 Enzymes,"GHIAUR, GABRIEL",JOHNS HOPKINS UNIVERSITY,MD,"$171,720"
Pediatric Cancer,2016,NCI,4R01CA163452-04,,Novel lysine deacetylase 6 Hsp domain inhibitors against AML,"CHOU, CHUNG-JEN JAMES",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$310,213"
Pediatric Cancer,2016,NCI,5R01CA193842-02,,Characterizing MSI2 in leukemia,"KHARAS, MICHAEL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$414,827"
Pediatric Cancer,2016,NCI,4R01CA124709-09,,The Genetic Basis of Neuroblastoma Tumorigenesis,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$614,290"
Pediatric Cancer,2016,NINDS,5R01NS091219-02,,Targeting Wee1 in Myc driven Medulloblasoma,"VIBHAKAR, RAJEEV",UNIVERSITY OF COLORADO DENVER,CO,"$255,118"
Pediatric Cancer,2016,NICHD,4P50HD076188-04,6685,Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer,"KURITA, TAKESHI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$331,241"
Pediatric Cancer,2016,NCI,4R01CA114567-10,,Targeted therapy in ex vivo medulloblastoma/PNET,"OLSON, JAMES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$227,292"
Pediatric Cancer,2016,NCI,4R01CA174794-04,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$642,665"
Pediatric Cancer,2016,NICHD,5R01HD081123-02,,Personalized Whole Body Staging for Children with Cancer: A Solution to the Conundrum of Long-Term Side Effects from CT and PET/CT Scans,"DALDRUP-LINK, HEIKE",STANFORD UNIVERSITY,CA,"$487,628"
Pediatric Cancer,2016,NCI,1R01CA192176-01A1,,Developmental studies to inform clinical stratification and targeting of SHH MB,"JOYNER, ALEXANDRA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$484,999"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7522,Genomics of AML Clonality,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$331,298"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7523,Genomics of AML Relapse,"DIPERSIO, JOHN",WASHINGTON UNIVERSITY,MO,"$333,043"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7524,Genomics of Familial MDS/AML,"GRAUBERT, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$338,993"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7525,Genomics of Teatment-Related AML,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$336,859"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7526,Clinical Database,"WESTERVELT, PETER",WASHINGTON UNIVERSITY,MO,"$268,229"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7527,"Specimen Acquisition, Genomic, Transcriptomic and Epigenetic Profilling","PAYTON, JACQUELINE",WASHINGTON UNIVERSITY,MO,"$227,227"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7528,Sequencing and Integrated Analysis of AML Genomes,"WILSON, RICHARD",WASHINGTON UNIVERSITY,MO,"$902,342"
Pediatric Cancer,2016,NCI,4P01CA101937-13,7529,Administration,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$150,298"
Pediatric Cancer,2016,NCI,4R01CA175759-04,,Creating and Validating Child Adverse Event Reporting in Oncology Trials,"REEVE, BRYCE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,$1
Pediatric Cancer,2016,NCI,5UM1CA183730-03,,Collaborative Human Tissue Network (CHTN),"RAMIREZ, NILSA",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$774,914"
Pediatric Cancer,2016,NCI,5F30CA183497-03,,Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia,"MCKENNEY, ANNA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$48,576"
Pediatric Cancer,2016,NCI,1R01CA197903-01A1,,Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma,"ZHONG, JOHN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$394,607"
Pediatric Cancer,2016,NCI,5U01CA183030-03,,Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML,"LIU, YANG",CHILDREN'S RESEARCH INSTITUTE,DC,"$472,123"
Pediatric Cancer,2016,NIDDK,4K08DK091360-06,,Characterization of Genetic Abnormalities in MDS and Their Clinical Impact,"BEJAR, RAFAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$157,442"
Pediatric Cancer,2016,NCI,1U01CA202943-01,,Developing a translational pipeline for NF1-mutant malignancies,"CICHOWSKI, KAREN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$578,917"
Pediatric Cancer,2016,NCI,5R01CA133379-08,,The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$381,375"
Pediatric Cancer,2016,NIMHD,5R01MD007801-03,,Reducing racial/ethnic inequities in childhood cancer survivorship,"MILAM, JOEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$412,142"
Pediatric Cancer,2016,NCI,5R01CA090576-16,,Studies of BCR-ABL leukemogenesis in mice,"VAN ETTEN, RICHARD",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$274,559"
Pediatric Cancer,2016,NCI,4R01CA166749-04,,The Role of Growth Factor Receptor Trafficking in Tumorigenesis,"ZAGE, PETER",BAYLOR COLLEGE OF MEDICINE,TX,"$318,913"
Pediatric Cancer,2016,NCI,5R03CA195618-02,,Biomarkers in pediatric versus adult myelodysplastic syndromes,"VERNERIS, MICHAEL",UNIVERSITY OF MINNESOTA,MN,"$76,000"
Pediatric Cancer,2016,NCI,5R01CA175353-03,,Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu,"ROBINS, HARLAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$648,389"
Pediatric Cancer,2016,NCI,4R01CA161780-05,,Genetic Risk Factors for Ewing's Sarcoma,"SCHIFFMAN, JOSHUA",UNIVERSITY OF UTAH,UT,"$573,919"
Pediatric Cancer,2016,NCI,4R01CA177307-04,,Targeting the MLL-WDR5 protein-protein interaction,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN,MI,"$451,476"
Pediatric Cancer,2016,NCI,5R01CA195692-02,,Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management,"GUTMANN, DAVID",WASHINGTON UNIVERSITY,MO,"$564,104"
Pediatric Cancer,2016,NCI,5F31CA196045-02,,The role of PRDM16 in Leukemia,"CORRIGAN, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$40,602"
Pediatric Cancer,2016,NCI,4R01CA175215-04,,Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer,"RADICH, JERALD",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$585,953"
Pediatric Cancer,2016,NCI,4R01CA163870-04,,Comb External Beam Radiotherapy with 153Sm-EDTMP to Treat High Risk Osteosarcoma,"LOEB, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$188,970"
Pediatric Cancer,2016,NINDS,5R01NS078092-06,,A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets,"LU, QING",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$341,250"
Pediatric Cancer,2016,NCI,4R01CA166616-05,,Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML,"SHAH, NEIL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$320,588"
Pediatric Cancer,2016,NCI,4R01CA176091-04,,Crenolanib and ponatinib for the treatment of FLT3 mutant AML,"SHAH, NEIL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Pediatric Cancer,2016,NCI,5R01CA172067-05,,Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma,"DUBOIS, STEVEN",DANA-FARBER CANCER INST,MA,"$363,426"
Pediatric Cancer,2016,NCI,4R01CA101774-14,,Mechanisms of Leukemogenesis in Down Syndrome,"CRISPINO, JOHN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$303,965"
Pediatric Cancer,2016,NCI,7R01CA194094-02,,Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML,"LI, HONG-YU",UNIV OF ARKANSAS FOR MED SCIS,AR,"$370,810"
Pediatric Cancer,2016,NCI,1F31CA203252-01,,Determining the Role of Tumor-Associated Macrophages in oHSV Antitumor Efficacy in Ewing Sarcoma and Rhabdomyosarcoma,"DENTON, NICHOLAS",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$34,664"
Pediatric Cancer,2016,NCI,4R01CA151535-05,,Role of TET proteins in myeloid malignancies,"RAO, ANJANA",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$370,180"
Pediatric Cancer,2016,NCI,1R43CA203172-01,,A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia,"MU, XUEYAN","TEAMEDON INTERNATIONAL, LLC",MD,"$278,000"
Pediatric Cancer,2016,NCI,1R43CA203166-01,,Novel Bone-Targeting Combination Therapy for Osteosarcoma,"ZINNEN, SHAWN","MBC RESEARCH, INC.",CO,"$301,877"
Pediatric Cancer,2016,NCI,1R43CA203351-01,,Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS,"MORGAN, LEE","DEKK-TEC, INC.",LA,"$90,362"
Pediatric Cancer,2016,NCI,5R21CA195689-02,,Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes,"NAORA, HONAMI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Pediatric Cancer,2016,NCI,1F32CA203049-01,,Targeting PRL2 phosphatase in acute myeloid leukemia,"NABINGER, SARAH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$61,137"
Pediatric Cancer,2016,NCI,1F31CA203053-01,,The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis,"SECHLER, MARYBETH",UNIVERSITY OF COLORADO DENVER,CO,"$32,837"
Pediatric Cancer,2016,NCI,5U01CA176063-03,,ARID5B and disparities of childhood leukemia,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$365,074"
Pediatric Cancer,2016,NCI,5R01CA177810-02,,Modulation of MicroRNAs with Xenobiotics to Target c-Myc,"LI, YONG",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$368,859"
Pediatric Cancer,2016,NICHD,5R00HD070953-05,,Risk and Protective Factors for Immune Health in Pediatric Cancer,"WINTER, MARCIA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$231,138"
Pediatric Cancer,2016,NCI,1F31CA203161-01,,"Targeting PARP and RAD52 to induce ""dual synthetic lethality"" in leukemia patients identified by gene expression and mutation profiling","SULLIVAN, KATHERINE",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$29,195"
Pediatric Cancer,2016,NIDDK,1F30DK108532-01,,microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.,"WEISS, CARY","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$48,576"
Pediatric Cancer,2016,NCI,1F30CA203292-01,,"Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies","SWAROOP, ALOK",UNIVERSITY OF FLORIDA,FL,"$37,411"
Pediatric Cancer,2016,NCATS,1R13CA203289-01,,Developing Endpoints to Facilitate Clinical Trials in Rare Diseases,"PLOTKIN, SCOTT",MASSACHUSETTS GENERAL HOSPITAL,MA,"$6,000"
Pediatric Cancer,2016,NCI,1R13CA203289-01,,Developing Endpoints to Facilitate Clinical Trials in Rare Diseases,"PLOTKIN, SCOTT",MASSACHUSETTS GENERAL HOSPITAL,MA,"$3,993"
Pediatric Cancer,2016,NCI,1R01CA197991-01A1,,Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia,"PARDEE, TIMOTHY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$354,563"
Pediatric Cancer,2016,NCI,5F30CA192832-02,,ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development,"LANG, YUN LONG",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$33,814"
Pediatric Cancer,2016,NCI,5R01CA132946-09,,Pharmacogenomics of Ara-C in AML,"LAMBA, JATINDER",UNIVERSITY OF FLORIDA,FL,"$310,509"
Pediatric Cancer,2016,NCI,5R01CA193890-02,,HAUSP inhibitors in p53-wild type and p53-mutant tumors,"GU, WEI",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Pediatric Cancer,2016,NHLBI,5R01HL052725-22,,Molecular Pathogenesis of Fanconi Anemia,"D'ANDREA, ALAN",DANA-FARBER CANCER INST,MA,"$400,792"
Pediatric Cancer,2016,NCI,4R01CA158350-05,,Targeting the aberrant kinome-epigenome in AML,"GARZON, RAMIRO",OHIO STATE UNIVERSITY,OH,"$308,958"
Pediatric Cancer,2016,NCI,5R01CA178030-03,,Regulation of transcription and tumor suppression by MTG family members,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$364,000"
Pediatric Cancer,2016,NCI,5R01CA185402-03,,(PQD-5) Patient derived orthotopic xenograft models for drug response prediction,"LI, XIONAN",BAYLOR COLLEGE OF MEDICINE,TX,"$322,828"
Pediatric Cancer,2016,NCI,4R01CA154561-06,,Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy,"SEO, YOUNGHO","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$350,001"
Pediatric Cancer,2016,NCI,5F30CA196244-02,,The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors,"SCOVILLE, STEVEN",OHIO STATE UNIVERSITY,OH,"$48,576"
Pediatric Cancer,2016,NCI,5R01CA174851-03,,A longitudinal assessment of frailty in young adult survivors of childhood cancer,"NESS, KIRSTEN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$535,247"
Pediatric Cancer,2016,NCI,4R01CA166025-04,,Molecular Basis of Familial Paraganglioma,"MAHER, LOUIS",MAYO CLINIC ROCHESTER,MN,"$296,933"
Pediatric Cancer,2016,NCI,5K08CA174750-03,,Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy,"CAPITINI, CHRISTIAN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$178,740"
Pediatric Cancer,2016,NCI,5U24CA196173-02,,COG Biospecimen Bank,"RAMIREZ, NILSA",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$2,244,903"
Pediatric Cancer,2016,NCI,4R01CA175231-04,,Reducing Skin Cancer Risk in Childhood Cancer Survivors,"GELLER, ALAN",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$638,094"
Pediatric Cancer,2016,NCI,5R21CA194217-02,,Targeting osteoblasts to inhibit AML,"HEDIN, KAREN",MAYO CLINIC ROCHESTER,MN,"$172,913"
Pediatric Cancer,2016,NIAID,5R21AI119894-02,,Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$227,372"
Pediatric Cancer,2016,NCI,4U01CA168426-05,,Systems Biology of Tumor Progression and Drug Resistance,"CALIFANO, ANDREA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,238,106"
Pediatric Cancer,2016,NCI,5R01CA175761-03,,Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis,"PERKINS, ARCHIBALD",UNIVERSITY OF ROCHESTER,NY,"$356,888"
Pediatric Cancer,2016,NHLBI,5R01HL114582-03,,Role of TRAF6 in Myelodysplastic Syndromes,"STARCZYNOWSKI, DANIEL",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$398,308"
Pediatric Cancer,2016,NIEHS,4R01ES022054-05,,Study DNA repair in preventing MDS and AML after radiation and benzene exposure,"HASTY, EDWARD",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$334,415"
Pediatric Cancer,2016,NCI,4R01CA168622-04,,"Cell Fate Control by Integrated E2F, FoxO and PI3K Signaling in Retinoblastoma","HALLSTROM, TIMOTHY",UNIVERSITY OF MINNESOTA,MN,"$315,400"
Pediatric Cancer,2016,NCI,4R01CA159013-05,,Online Problem-Solving Skills Training for Mothers of Childhood Cancer Patients,"SAHLER, OLLE JANE",UNIVERSITY OF ROCHESTER,NY,"$752,832"
Pediatric Cancer,2016,NIDCR,5R01DE024392-03,,Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells,"VIGNESWARAN, NADARAJAH",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$383,817"
Pediatric Cancer,2016,NIGMS,4R01GM101087-05,,Dissecting the Signaling Mechanisms of Smoothened,"OGDEN, STACEY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$336,875"
Pediatric Cancer,2016,NCI,5R00CA168996-04,,The role of Jmjd1c in normal and leukemic hematopoiesis,"ZHU, NAN","BLOODCENTER OF WISCONSIN, INC.",WI,"$243,927"
Pediatric Cancer,2016,NCI,5R21CA194608-02,,Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy,"GARTEL, ANDREI",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$173,873"
Pediatric Cancer,2016,NCI,5R03CA188733-02,,Genetic susceptibility to acute lymphocytic and myeloid leukemia,"HAHN, THERESA",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$87,750"
Pediatric Cancer,2016,NCI,5R01CA194552-02,,RETARGETING AGENTS TO TREAT AML,"DIPERSIO, JOHN",WASHINGTON UNIVERSITY,MO,"$380,068"
Pediatric Cancer,2016,NCI,5K08CA194256-02,,Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML),"GILL, SAAR",UNIVERSITY OF PENNSYLVANIA,PA,"$167,832"
Pediatric Cancer,2016,NCI,4R01CA169162-05,,Targeting non-classical oncogenes as therapy for T-ALL,"DIACOVO, THOMAS",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Pediatric Cancer,2016,NINDS,5R01NS085336-03,,Pediatric low-grade gliomas: biology and molecular targeting.,"RESNICK, ADAM",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$367,500"
Pediatric Cancer,2016,NCI,5R01CA173852-03,,Role of p21 activated kinase in Leukemogenesis,"KAPUR, REUBEN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Pediatric Cancer,2016,NCI,5R01CA193776-02,,Improving risk allocation and developing novel therapies for children with T-ALL,"TEACHEY, DAVID",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$626,176"
Pediatric Cancer,2016,NCI,5R01CA194923-02,,Long non-coding RNAs in hematopoiesis and blood malignancy,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$457,533"
Pediatric Cancer,2016,NCI,5R01CA098571-12,,Molecular Mechanisms of eIF4E mediated transformation,"BORDEN, KATHERINE",UNIVERSITY OF MONTREAL,CANADA,"$227,057"
Pediatric Cancer,2016,NCI,4U01CA176287-04,,Genetic network analysis of cancer targets,"WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$308,486"
Pediatric Cancer,2016,NCI,5F32CA183527-03,,Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers,"ONDRUS, ALISON",STANFORD UNIVERSITY,CA,"$64,146"
Pediatric Cancer,2016,NCI,5R01CA185062-03,,(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia,"FARRAR, MICHAEL",UNIVERSITY OF MINNESOTA,MN,"$312,341"
Pediatric Cancer,2016,NCI,4R01CA154619-05,,Anticancer Drug Pharmacology in Very Young Children,"STEWART, CLINTON",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$433,475"
Pediatric Cancer,2016,NCI,4R01CA161202-05,,Functional analysis of leukemic CREBBP mutations,"MULLIGHAN, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$363,125"
Pediatric Cancer,2016,NCI,5R01CA182633-03,,Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma,"ASGHARZADEH, SHAHAB",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$665,155"
Pediatric Cancer,2016,NCI,5R01CA188516-03,,Cooperating Pathways in Gliomagenesis,"BAKER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$372,203"
Pediatric Cancer,2016,NCI,5R21CA198392-02,,A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatric solid tumors,"OTTO, MARIO",UNIVERSITY OF WISCONSIN-MADISON,WI,"$166,388"
Pediatric Cancer,2016,NCI,5R01CA190509-02,,The function of cyclin C in tumorigenesis,"SICINSKI, PETER",DANA-FARBER CANCER INST,MA,"$453,569"
Pediatric Cancer,2016,NCI,5R21CA181875-02,,Cdk5 signaling in ICN1-induced T Cell Leukemogenesis,"HUANG, ALEX",CASE WESTERN RESERVE UNIVERSITY,OH,"$172,369"
Pediatric Cancer,2016,NCI,4R01CA178765-04,,Transcriptional regulatory mechanisms in B cell development and leukemogenesis,"ROEDER, ROBERT",ROCKEFELLER UNIVERSITY,NY,"$565,455"
Pediatric Cancer,2016,NCI,4R01CA162665-05,,Targeting Leukemia Stem Cells with Dietary Selenium,"PRABHU, KUMBLE",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$303,222"
Pediatric Cancer,2016,NCI,5R01CA169368-04,,Therapeutic Exploitation of Mutant BRAF for Astrocytoma,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$138,308"
Pediatric Cancer,2016,NCI,4R01CA171972-04,,Targeted Elimination of Cancer Stem Cells for AML Therapy,"LIU, YANG",CHILDREN'S RESEARCH INSTITUTE,DC,"$463,347"
Pediatric Cancer,2016,NCI,4R01CA166327-04,,Regulation of Tumor Metabolism by Retinoblastoma Protein,"CLEM, BRIAN",UNIVERSITY OF LOUISVILLE,KY,"$195,750"
Pediatric Cancer,2016,NCI,5R01CA185058-03,,Impact of low IL-10 levels at birth and leukemia risk,"WIEMELS, JOSEPH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$624,355"
Pediatric Cancer,2016,NINDS,5R01NS088355-02,,Targeting BET-bromodomains in neuroblastoma,"WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$669,055"
Pediatric Cancer,2016,NCI,4R01CA172385-04,,Validation and Development of WEE1 as a therapeutic target in AML,"PORTER, CHRISTOPHER",UNIVERSITY OF COLORADO DENVER,CO,"$316,213"
Pediatric Cancer,2016,NIDDK,5R01DK103961-04,,Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes,"VERMA, AMIT","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$358,005"
Pediatric Cancer,2016,NCI,5R01CA192652-02,,Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media,"BULLER, DAVID","KLEIN BUENDEL, INC.",CO,"$671,522"
Pediatric Cancer,2016,NCI,5R01CA140198-08,,Targeting Oncogenic ALK Signaling in Neuroblastoma,"MOSSE, YAEL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$374,344"
Pediatric Cancer,2016,NCI,5R01CA182284-04,,Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats,"COLE, PETER","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$346,525"
Pediatric Cancer,2016,NCI,5R01CA183776-04,,"(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma","LESSNICK, STEPHEN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$309,175"
Pediatric Cancer,2016,NICHD,5R01HD080952-03,,The Reproductive Window in Young Adult Cancer Survivors,"SU, HUI-CHUN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$567,917"
Pediatric Cancer,2016,NCI,5R01CA173877-04,,Targeted Therapy for AML Stem Cells,"BHALLA, KAPIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Pediatric Cancer,2016,NCI,5R01CA171338-04,,Novel Targeted Therapy for AML,"BHALLA, KAPIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Pediatric Cancer,2016,NCI,5R01CA185039-03,,(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu,"JAN, LILY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$373,436"
Pediatric Cancer,2016,NCI,5R01CA064140-23,,Role of AML1-ETO in Acute Leukemia,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$353,250"
Pediatric Cancer,2016,NCI,5R21CA198049-02,,Pediatric Cancer Interdisciplinary Team Training for Regoaling CARE Discussions,"FEUDTNER, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$182,700"
Pediatric Cancer,2016,NIDDK,5R01DK100960-03,,Hematopoiesis in Down Syndrome iPS cells: Correction by Chromosome 21 Silencing,"LAWRENCE, JEANNE",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$291,450"
Pediatric Cancer,2016,NHLBI,5F30HL128011-02,,HSC-Independent Progenitors Contribute to Juvenile Myelomonocytic Leukemia,"TARNAWSKY, STEFAN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$27,801"
Pediatric Cancer,2016,NCI,4R01CA173085-04,,Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia,"BRAUN, BENJAMIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Pediatric Cancer,2016,NCI,5R01CA174808-03,,Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells,"SHOHET, JASON",BAYLOR COLLEGE OF MEDICINE,TX,"$326,348"
Pediatric Cancer,2016,NCI,5U01CA184898-03,,Embryonal Brain Tumor Networks,"FRAENKEL, ERNEST",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$725,409"
Pediatric Cancer,2016,NCI,5R21CA198698-02,,Prenatal stress and neuroblastoma development - is there a link?,"KITLINSKA, JOANNA",GEORGETOWN UNIVERSITY,DC,"$169,106"
Pediatric Cancer,2016,NCI,5R01CA195563-02,,Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas,"MITCHELL, DUANE",UNIVERSITY OF FLORIDA,FL,"$492,969"
Pediatric Cancer,2016,NCI,5R01CA172408-03,,Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies,"YANG, FENG-CHUN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$318,513"
Pediatric Cancer,2016,NCI,1P50CA196516-01A1,6943,Core B: Biospecimen and Pathology Resources Core,"KAPUR, PAYAL",UT SOUTHWESTERN MEDICAL CENTER,TX,"$356,841"
Pediatric Cancer,2016,NCI,1P50CA196516-01A1,6951,Project 4: Prognostic Significance and Therapeutic Potential of DROSHA Mutations in Wilms Tumor,"AMATRUDA, JAMES",UT SOUTHWESTERN MEDICAL CENTER,TX,"$299,672"
Pediatric Cancer,2016,NCI,5F31CA196265-02,,Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions,"DORAND, RODNEY",CASE WESTERN RESERVE UNIVERSITY,OH,"$29,633"
Pediatric Cancer,2016,NCI,4R01CA090321-14,,Role of Sialic Acid Modification in ALL Survival and Drug Resistance,"HEISTERKAMP, NORA",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$266,069"
Pediatric Cancer,2016,NCI,4R01CA172723-04,,Predicting deficits in social competence for pediatric brain tumor survivors,"VANNATTA, KATHRYN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$335,532"
Pediatric Cancer,2016,NCI,5R01CA188269-03,,Developing CRM1 inhibitors in AML,"GARZON, RAMIRO",OHIO STATE UNIVERSITY,OH,"$319,550"
Pediatric Cancer,2016,NCI,2R25CA023944-33,,PEDIATRIC ONCOLOGY EDUCATION (YEARS 33 - 37),"GRONEMEYER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$321,271"
Pediatric Cancer,2016,NCI,2P30CA013148-44,8603,04 Neuro-Oncology Program,"GILLESPIE, G.",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$31,120"
Pediatric Cancer,2016,NCI,1R01CA204586-01,,Yap and beta-catenin interactions in liver: Implications in Pathophysiology,"MONGA, SATDARSHAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$425,315"
Pediatric Cancer,2016,NCI,4R01CA172896-04,,Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells,"KIM, YONG-MI",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$335,154"
Pediatric Cancer,2016,NHLBI,1R01HL131744-01,,Molecular Genetics of Dyskeratosis Congenita,"BERTUCH, ALISON",BAYLOR COLLEGE OF MEDICINE,TX,"$522,587"
Pediatric Cancer,2016,NCI,4R01CA160747-05,,DISCOVERY OF SMALL MOLECULAR ACTIVATORS OF NR4A ORPHAN NUCLEAR RECEPTORS,"CONNEELY, ORLA",BAYLOR COLLEGE OF MEDICINE,TX,"$324,738"
Pediatric Cancer,2016,NCI,1R01CA204308-01,,Modulating signaling pathways in endothelial cells to abate leukemic progression.,"BUTLER, JASON",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$383,445"
Pediatric Cancer,2016,NINDS,1R01NS096236-01,,Targeting mechanisms of medulloblastoma formation,"VAN MEIR, ERWIN",EMORY UNIVERSITY,GA,"$386,460"
Pediatric Cancer,2016,NINDS,1R01NS096368-01,,Regulation of Medulloblastoma Metastasis by Emp1,"WECHSLER-REYA, ROBERT",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$426,563"
Pediatric Cancer,2016,NCI,5UM1CA081457-18,,Pediatric Brain Tumor Consortium (PBTC),"ONAR-THOMAS, ARZU",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$2,711,401"
Pediatric Cancer,2016,NCI,4R01CA164120-04,,Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia,"PARK, CHRISTOPHER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$366,860"
Pediatric Cancer,2016,NCI,5R25CA183725-02,,Problem-Solving Skills Training for Clinicians Providing Psychosocial Care in Pediatric Oncology,"SAHLER, OLLE JANE",UNIVERSITY OF ROCHESTER,NY,"$309,623"
Pediatric Cancer,2016,NHLBI,4R33HL123655-03,,hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin Cardiotoxicity,"BERNSTEIN, DANIEL",STANFORD UNIVERSITY,CA,"$488,873"
Pediatric Cancer,2016,NCI,5R01CA057138-25,,Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways,"EISENMAN, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$635,460"
Pediatric Cancer,2016,NCI,4R01CA121113-10,,Large-scale Genetic Analyses of Human Cancer,"VELCULESCU, VICTOR",JOHNS HOPKINS UNIVERSITY,MD,"$279,212"
Pediatric Cancer,2016,NINR,5R01NR015353-03,,Impact of a PCRC-Supported Legacy Intervention in Pediatric Palliative Care,"FOSTER, TERRAH",VANDERBILT UNIVERSITY,TN,"$446,830"
Pediatric Cancer,2016,NCI,5R25CA102618-13,,Cancer Control Research Training Curriculum,"MORROW, GARY",UNIVERSITY OF ROCHESTER,NY,"$455,585"
Pediatric Cancer,2016,NCI,4R01CA168875-05,,Molecular Targeted Therapy for Retinoblastoma,"DYER, MICHAEL",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$363,125"
Pediatric Cancer,2016,NCI,5R01CA189806-03,,Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$576,703"
Pediatric Cancer,2016,NCI,1K99CA204593-01,,Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer,"ALTMAN, BRIAN",UNIVERSITY OF PENNSYLVANIA,PA,"$86,521"
Pediatric Cancer,2016,NCI,1K08CA204734-01,,Determining the Role of BCOR Mutations in Myeloid Malignancies,"LINDSLEY, ROBERT",DANA-FARBER CANCER INST,MA,"$176,970"
Pediatric Cancer,2016,NCI,4R01CA113636-10,,Sleeping Beauty for uncovering cancer genes in mice,"LARGAESPADA, DAVID",UNIVERSITY OF MINNESOTA,MN,"$251,592"
Pediatric Cancer,2016,NCI,5R01CA195218-02,,Innovative solutions to spatial uncertainty in geocoding,"COCKBURN, MYLES",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$377,438"
Pediatric Cancer,2016,NCI,1R03CA186910-01A1,,Parenting in the Face of Cancer: Non-Ill Sibling and Parent Relationships,"WALKER, AMY",UNIVERSITY OF WASHINGTON,WA,"$77,250"
Pediatric Cancer,2016,NCI,4R01CA044722-26,,Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer,"STUDZINSKI, GEORGE",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,"$203,601"
Pediatric Cancer,2016,NCI,4P01CA119070-10,7559,Notch Target Gene Regulation in Normal and Malignant T Cells,"PEAR, WARREN",UNIVERSITY OF PENNSYLVANIA,PA,"$295,553"
Pediatric Cancer,2016,NCI,4P01CA119070-10,7562,Bioinformatics Core,"LIU, XIAOLE",DANA-FARBER CANCER INST,MA,"$80,878"
Pediatric Cancer,2016,NINDS,1R21NS096502-01,,Elucidating the drivers of medulloblastoma initiation and recurrence,"ROBBINS, DAVID",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$230,250"
Pediatric Cancer,2016,NIDCR,1R34DE025908-01,,Extraorally delivered lo level light therapy for prevention of oropharyngeal mucositis in pediatric patients undergoing hematopoietic stem cell transplantation,"TREISTER, NATHANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$322,079"
Pediatric Cancer,2016,NCI,4R01CA102321-13,,Murine Neuroblastoma Models for Preclinical Therapeutics,"WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$261,089"
Pediatric Cancer,2016,NCI,4R01CA168903-05,,Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma,"SHAPIRO, LINDA",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$345,402"
Pediatric Cancer,2016,NCI,4P50CA171963-04,8326,Molecular Determinants of Decitabine Response,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$368,008"
Pediatric Cancer,2016,NCI,4P50CA171963-04,8328,RNA Splicing Modulators for MDS/AML,"GRAUBERT, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$401,522"
Pediatric Cancer,2016,NCI,4T32CA060441-24,,Lab Research Training in Pediatric Oncology-Hematology,"SMALL, DONALD",JOHNS HOPKINS UNIVERSITY,MD,"$579,554"
Pediatric Cancer,2016,NINDS,5F31NS086367-03,,Identifying the Second Hit in MYC-driven Medulloblastoma; a Role for Gfi Proteins,"LEE, CATHERINE",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$5,467"
Pediatric Cancer,2016,NCI,1R01CA204585-01,,SCH: INT: Collaborative  Research Intelligent Information Sharing: Advancing Teamwork in Complex Care,"GROSZ, BARBARA",HARVARD UNIVERSITY,MA,"$416,894"
Pediatric Cancer,2016,NCI,2K12CA076930-16A1,,Career Development in Pediatric and Medical Oncology,"BERNSTEIN, IRWIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$531,466"
Pediatric Cancer,2016,NCI,5R01CA175026-03,,Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML,"REDELL, MICHELE",BAYLOR COLLEGE OF MEDICINE,TX,"$402,343"
Pediatric Cancer,2016,NCI,5F30CA186633-03,,Defining novel drivers and predictive signatures of metastasis in osteosarcoma th,"MORROW, JAMES",CASE WESTERN RESERVE UNIVERSITY,OH,"$43,576"
Pediatric Cancer,2016,NHLBI,4K08HL111280-05,,Beta-catenin is a molecular target of the Fanconi anemia core complex,"DAO, KIM-HIEN",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$157,680"
Pediatric Cancer,2016,NCI,1R01CA196882-01A1,,Characterizing Histone Deacetylases in Rhabdomyosarcoma,"CHEN, ELEANOR",UNIVERSITY OF WASHINGTON,WA,"$295,138"
Pediatric Cancer,2016,NCI,4R01CA169398-05,,Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment,"HOCKENBERRY, MARILYN",DUKE UNIVERSITY,NC,"$603,111"
Pediatric Cancer,2016,NIGMS,4P30GM106396-04,8530,Animal Model Core,"CHESNEY, JASON",UNIVERSITY OF LOUISVILLE,KY,"$241,773"
Pediatric Cancer,2016,NCI,4R01CA163926-04,,Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,"GREEN, MICHAEL",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$347,563"
Pediatric Cancer,2016,NIGMS,5P50GM115279-02,7544,CPML - Core A: Administrative Core,"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$204,478"
Pediatric Cancer,2016,NIGMS,5P50GM115279-02,7545,CPML - Core B: Cell & Molecular Core,"CREWS, KRISTINE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$348,034"
Pediatric Cancer,2016,NIGMS,5P50GM115279-02,7546,CPML - Core C: Bioinformatics & Biostatistical Core,"ZHANG, JINGHUI",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$596,871"
Pediatric Cancer,2016,NIGMS,5P50GM115279-02,7547,CPML - Project 1: Genome-wide Studies of ALL Response,"MULLIGHAN, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$737,381"
Pediatric Cancer,2016,NIGMS,5P50GM115279-02,7548,CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity,"EVANS, WILLIAM",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$698,840"
Pediatric Cancer,2016,NIGMS,5P50GM115279-02,7549,CPML - Project 3: Genome-wide Studies of Adverse Effects,"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$384,140"
Pediatric Cancer,2016,NCI,5R01CA084628-24,,"Telomerase in Development, Senescence and Neoplasia","DEPINHO, RONALD",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$616,000"
Pediatric Cancer,2016,NCI,5R21CA178605-02,,T cell TGF-beta signaling as a therapeutic target for pediatric brain tumors,"TOWN, TERRENCE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$179,438"
Pediatric Cancer,2016,NCI,4R01CA178979-04,,CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML,"TIBES, RAOUL",MAYO CLINIC ARIZONA,AZ,"$344,450"
Pediatric Cancer,2016,NCI,5K08CA190815-02,,REGULATORY MECHANISMS OF HOX GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA,"SPENCER, DAVID",WASHINGTON UNIVERSITY,MO,"$166,298"
Pediatric Cancer,2016,NCI,4R01CA114563-10,,Biology and Prognostic Implications of FLT3 Mutations in AML,"MESHINCHI, SOHEIL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$429,543"
Pediatric Cancer,2016,NCI,5R01CA187202-03,,Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor,"KAHALLEY, LISA",BAYLOR COLLEGE OF MEDICINE,TX,"$102,827"
Pediatric Cancer,2016,NCI,1R21CA205309-01,,National trends in end of life care for adolescent and young adult cancer patients,"WERNLI, KAREN",GROUP HEALTH COOPERATIVE,WA,"$256,238"
Pediatric Cancer,2016,NCI,1R03CA205311-01,,Development of a mouse model of pediatric high-grade gliomas,"XIE, ZHIGANG",TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,TX,"$74,250"
Pediatric Cancer,2016,NCI,5P30CA014236-42,5328,Neuro-Oncology Research Program,"KASTAN, MICHAEL",DUKE UNIVERSITY,NC,"$40,784"
Pediatric Cancer,2016,NCI,5R01CA189074-02,,Small molecule CXCR4 modulators as molecular probes for studying AML,"SCHILTZ, GARY",NORTHWESTERN UNIVERSITY,IL,"$539,886"
Pediatric Cancer,2016,NHLBI,5R01HL126947-02,,Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes,"FIGUEROA, MARIA",UNIVERSITY OF MICHIGAN,MI,"$390,375"
Pediatric Cancer,2016,NIGMS,7P20GM103639-05,7853,TARGETED IMMUNOLIPOSOMAL EF24 AGAINST REL ORCHESTRATED NEUR (Natarajan Aravindan),"ARAVINDAN, NATARAJAN",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$222,000"
Pediatric Cancer,2016,NCI,1R21CA195324-01A1,,Targeting insulin receptor splicing for treatment of rhabdomyosarcoma,"CHANDLER, DAWN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$196,022"
Pediatric Cancer,2016,NCI,1R21CA205644-01,,(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy,"WHITESIDE, THERESA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$167,475"
Pediatric Cancer,2016,NCI,5T32CA099936-12,,Translational Pediatric Cancer Epidemiology Research Training Grant,"SPECTOR, LOGAN",UNIVERSITY OF MINNESOTA,MN,"$229,057"
Pediatric Cancer,2016,NCI,4K08CA166229-04,,HISTONE H3 METHYLATION AND EPIGENOMICS IN ACUTE LEUKEMIA,"WARTMAN, LUKAS",WASHINGTON UNIVERSITY,MO,"$153,699"
Pediatric Cancer,2016,NIGMS,5R01GM113100-02,,Gli1-selective inhibitors of the Hedgehog signaling pathway,"CHEN, JAMES",STANFORD UNIVERSITY,CA,"$350,738"
Pediatric Cancer,2016,NCI,1R21CA194871-01A1,,Role of EMSY protein complexes in the FA DNA repair pathway,"SOBECK, ALEXANDRA",UNIVERSITY OF MINNESOTA,MN,"$195,119"
Pediatric Cancer,2016,NCI,1R21CA205828-01,,Examining the role of normal hematopoiesis in supporting incipient myelodysplasia,"PERKINS, ARCHIBALD",UNIVERSITY OF ROCHESTER,NY,"$200,807"
Pediatric Cancer,2016,NCI,1R21CA197441-01A1,,Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$167,475"
Pediatric Cancer,2016,NCI,1R21CA205912-01,,Mediator Kinases and AML Cell Proliferation,"TAATJES, DYLAN",UNIVERSITY OF COLORADO,CO,"$208,967"
Pediatric Cancer,2016,NCI,2R01CA199111-32A1,,Opening of the Blood-Brain Barrier to Antitumor Agents,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$623,133"
Pediatric Cancer,2016,NCI,1R21CA205936-01,,SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia,"DEININGER, MICHAEL",UNIVERSITY OF UTAH,UT,"$196,402"
Pediatric Cancer,2016,NCI,5F30CA196123-02,,Mutations in Runx1 and epigenetic modifiers cooperate in leukemogenesis,"BELLISSIMO, DANA",UNIVERSITY OF PENNSYLVANIA,PA,"$47,711"
Pediatric Cancer,2016,NCI,4K12CA090433-15,,Pediatric Oncology Clinical Research Training Program,"POPLACK, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$805,190"
Pediatric Cancer,2016,NCI,4R01CA168452-04,,Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6,"CHOU, MARGARET",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$259,058"
Pediatric Cancer,2016,NCI,4K07CA166177-04,,Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation,"MOSTOUFI-MOAB, SOGOL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$164,901"
Pediatric Cancer,2016,NIBIB,1R01EB020613-01A1,,Rapid MRI acquisition for pediatric low-grade gliomas,"SETSOMPOP, KAWIN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$666,473"
Pediatric Cancer,2016,NCI,5P30CA013696-42,6105,Lymphoid Development and Malignancy Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Pediatric Cancer,2016,NCI,5P30CA013696-42,6127,Recruitment,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$95,447"
Pediatric Cancer,2016,NCI,5R01CA104509-12,,Molecular Mechanism of Leukemogenesis Involving AML1-ETO,"ZHANG, DONG-ER",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$331,313"
Pediatric Cancer,2016,NCI,5R01CA187318-02,,Molecular understanding of cytokine-Ras signals in leukemic bone marrow,"ROOSE, JEROEN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$353,777"
Pediatric Cancer,2016,NCI,4K08CA169809-05,,Metabolic contribution to cell viability and therapy resistance in the acute,"PARDEE, TIMOTHY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$167,980"
Pediatric Cancer,2016,NCI,5R01CA196854-02,,Reducing risk of Anthracycline-related heart failure after childhood cancer,"ARMENIAN, SARO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$669,859"
Pediatric Cancer,2016,NCI,5R21CA186912-02,,Targeting PKM2-InsP3R interaction to treat AML,"DISTELHORST, CLARK",CASE WESTERN RESERVE UNIVERSITY,OH,"$222,296"
Pediatric Cancer,2016,NINDS,5R01NS089868-03,,"MYCN, mTOR and translation control in medulloblastoma","WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$614,079"
Pediatric Cancer,2016,NCI,2R01CA096899-11,,Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis,"KELLIHER, MICHELLE",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$358,031"
Pediatric Cancer,2016,NCI,2R01CA151898-06A1,,CRLF2 signaling in B-cell acute lymphoblastic leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$392,969"
Pediatric Cancer,2016,NCI,1R01CA175216-01A1,,Testicular effects of modern chemotherapy regimens in osteosarcoma survivors,"SHNORHAVORIAN, MARGARETT",SEATTLE CHILDREN'S HOSPITAL,WA,"$699,129"
Pediatric Cancer,2016,NINR,1R01NR015789-01A1,,Mechanisms of Active Music Engagement to Improve Health Outcomes of Children with Cancer and Parents,"ROBB, SHERI",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$492,400"
Pediatric Cancer,2016,NCI,1R01CA196851-01A1,,Targeting vismodegib-resistant tumors using BH3 mimetics,"LUM, LAWRENCE",UT SOUTHWESTERN MEDICAL CENTER,TX,"$346,539"
Pediatric Cancer,2016,NCI,1R01CA190661-01A1,,Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype,"STIREWALT, DEREK",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$576,165"
Pediatric Cancer,2016,NCI,4P01CA018029-41,5857,Molecular Diagnostics,"RADICH, JERALD",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$135,000"
Pediatric Cancer,2016,NCI,1R01CA193339-01A1,,Defective Myoblast Fusion Signaling in Rhabdomyosarcoma Pathogenesis,"GALINDO, RENE",UT SOUTHWESTERN MEDICAL CENTER,TX,"$370,575"
Pediatric Cancer,2016,NCI,5K08CA191091-02,,Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia,"KNOECHEL, BIRGIT",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2016,NCI,2R01CA116548-11A1,,THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA,"METELITSA, LEONID",BAYLOR COLLEGE OF MEDICINE,TX,"$249,637"
Pediatric Cancer,2016,NCI,1R01CA197336-01A1,,Transcriptional CDKs as therapeutic targets in MYC-dependent cancers,"GEORGE, RANI",DANA-FARBER CANCER INST,MA,"$407,748"
Pediatric Cancer,2016,NCI,2R01CA143167-06A1,,DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome,"HILL, DANA",CHILDREN'S RESEARCH INSTITUTE,DC,"$425,390"
Pediatric Cancer,2016,NCI,1R01CA181231-01A1,,A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling,"REITER, JEREMY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,569"
Pediatric Cancer,2016,NCI,1R01CA201496-01A1,,Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia,"ROSEN, STEVEN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$499,409"
Pediatric Cancer,2016,NINR,5K23NR014902-03,,Treatment-related CNS Injury in Children with Brain Tumors,"BARON NELSON, MARY",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$131,250"
Pediatric Cancer,2016,NCI,5K08CA188073-02,,Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma,"CROMPTON, BRIAN",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2016,NCI,5K07CA196985-02,,Translational Approaches to Melanoma Prevention in Children at High Genetic Risk,"WU, YELENA",UNIVERSITY OF UTAH,UT,"$136,363"
Pediatric Cancer,2016,NCI,5U01CA199297-02,,Pediatric Preclinical Testing Consortium: Research Programs Non-CNS (U01),"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$610,422"
Pediatric Cancer,2016,NCI,5U01CA199287-02,,Pediatric Preclinical Testing Consortium,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$357,000"
Pediatric Cancer,2016,NCI,5R01CA199937-02,,Image-guided doxorubicin delivery for pediatric sarcomas,"CHOPRA, RAJIV",UT SOUTHWESTERN MEDICAL CENTER,TX,"$555,305"
Pediatric Cancer,2016,NCI,5U01CA195547-02,,The St. Jude Lifetime Cohort,"HUDSON, MELISSA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$1,685,927"
Pediatric Cancer,2016,NIDCD,1K23DC014291-01A1,,Prevention of Cisplatin-induced Hearing Loss in Children with Cancer,"ORGEL, ETAN",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$195,588"
Pediatric Cancer,2016,NCI,5R01CA197964-02,,Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor,"KITLINSKA, JOANNA",GEORGETOWN UNIVERSITY,DC,"$351,644"
Pediatric Cancer,2016,NCI,5U01CA199221-03,,Osteosarcoma: Patient Derived Xenograft Preclinical Testing,"GORLICK, RICHARD","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$260,103"
Pediatric Cancer,2016,NCI,5U01CA199222-02,,Pediatric Preclinical Testing Consortium: Coordinating Center,"ROWSHAN, SUDIE",RESEARCH TRIANGLE INSTITUTE,NC,"$477,025"
Pediatric Cancer,2016,NCI,5R21CA198358-02,,Novel therapeutics of targeting mTOR pathway in T-cell leukemia,"GUO, FUKUN",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$203,580"
Pediatric Cancer,2016,NCI,5R03CA199516-02,,Nutritional Intake in Adult Survivors of Childhood Cancer,"ZHANG, FANG FANG",TUFTS UNIVERSITY BOSTON,MA,"$87,142"
Pediatric Cancer,2016,NCI,5R21CA188881-02,,Phosphoproteomic signatures for early detection and stratification of AML,"MARTO, JARROD",DANA-FARBER CANCER INST,MA,"$190,852"
Pediatric Cancer,2016,NCI,5R01CA187079-02,,Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission),"CONKLIN, HEATHER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$432,966"
Pediatric Cancer,2016,NICHD,5R01CA187079-02,,Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission),"CONKLIN, HEATHER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$99,999"
Pediatric Cancer,2016,NCI,1K08CA184419-01A1,,Chemotherapy resistance induced by SETD2 loss in leukemia,"MAR, BRENTON",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2016,NCI,1K99CA197640-01A1,,Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor,"WANG, XIAOFENG",DANA-FARBER CANCER INST,MA,"$151,649"
Pediatric Cancer,2016,NCI,1K08CA194162-01A1,,The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblastoma,"SCHNEPP, ROBERT",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$73,224"
Pediatric Cancer,2016,NCI,1K99CA197484-01A1,,Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis,"HUANG, MILLER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$160,773"
Pediatric Cancer,2016,NCI,1K08CA181507-01A1,,Analysis of TET2 function in acute leukemia,"SHIH, ALAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$180,036"
Pediatric Cancer,2016,NINR,5K23NR014874-03,,Engaging School-Age Children with Cancer in Designing a Symptom Assessment App,"LINDER, LAURI",UNIVERSITY OF UTAH,UT,"$127,553"
Pediatric Cancer,2016,NCI,4K08CA169485-04,,Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W,"CHAPUIS, AUDE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$171,372"
Pediatric Cancer,2016,NCI,5U01CA199288-02,,In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models,"LI, XIONAN",BAYLOR COLLEGE OF MEDICINE,TX,"$578,693"
Pediatric Cancer,2016,NINDS,4R01NS061070-11,,Hedgehog:YAP:IGF2/mTOR axis in cerebellar precursor division and medulloblastoma,"KENNEY, ANNA",EMORY UNIVERSITY,GA,"$341,250"
Pediatric Cancer,2016,NCI,5F30CA189553-03,,Role of MLL1 and MLL1 leukemogenic fusions in maintaining transcriptional memory,"HSU, SARAH",UNIVERSITY OF PENNSYLVANIA,PA,"$30,341"
Pediatric Cancer,2016,NCI,5F32CA180615-03,,Molecular Mechanism of Osteoblastic Inhibition in Myeloid Malignancies,"FRISCH, BENJAMIN",UNIVERSITY OF ROCHESTER,NY,"$59,970"
Pediatric Cancer,2016,NCI,5R01CA196703-02,,Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma,"CHIARLE, ROBERTO",CHILDREN'S HOSPITAL CORPORATION,MA,"$404,888"
Pediatric Cancer,2016,NCI,5K99CA197869-02,,Functional dissection of oncogenic enhancers,"HERRANZ BENITO, DANIEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$170,856"
Pediatric Cancer,2016,NCI,5F31CA183342-02,,The Role of Shp2 Phosphatase Activity in FLT3-ITD+ Acute Myeloid Leukemia,"RICHINE, BRIANA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$37,324"
Pediatric Cancer,2016,NCI,4R01CA180037-04,,(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Pediatric Cancer,2016,NCI,5F32CA189741-03,,The role of ATRX and H3.3 mutations in pediatric glioblastoma,"ANASTAS, JAMIE",CHILDREN'S HOSPITAL CORPORATION,MA,"$57,002"
Pediatric Cancer,2016,NCI,5K08CA193915-02,,The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome,"KALISH, JENNIFER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$140,504"
Pediatric Cancer,2016,NCI,5R21CA191458-02,,Targeting alternative transcription/translation of RUNX1-ETO fusion gene,"ZHANG, JIWANG",LOYOLA UNIVERSITY CHICAGO,IL,"$164,213"
Pediatric Cancer,2016,NHLBI,5R01HL082945-10,,Functional Genomic Dissection of Refractory Anemia,"EBERT, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$443,750"
Pediatric Cancer,2016,NINR,5R01NR014248-03,,A Clinic-Based Interdisciplinary Intervention for Parents of Children with Cancer,"PAI, AHNA",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$633,139"
Pediatric Cancer,2016,NCI,4R01CA054498-25,,Late Effects of Treatment in Wilms Tumor Survivors and Offspring,"LEISENRING, WENDY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$636,039"
Pediatric Cancer,2016,NCI,5P30CA047904-28,6381,Clinical Protocol and Data Management/Clinical Trials Office (Core 016),"BRUFSKY, ADAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$532,275"
Pediatric Cancer,2016,NCI,5K08CA184418-03,,PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia,"TASIAN, SARAH",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$169,657"
Pediatric Cancer,2016,NCI,5R01CA198089-02,,Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia,"CARROLL, MARTIN",UNIVERSITY OF PENNSYLVANIA,PA,"$663,135"
Pediatric Cancer,2016,NCI,5R21CA198621-02,,How Does FLT3 Mutation Regulate Myeloid Differentiation in Acute Myeloid Leukemia,"CARROLL, MARTIN",UNIVERSITY OF PENNSYLVANIA,PA,"$208,880"
Pediatric Cancer,2016,NCI,5R01CA181024-03,,Prevention of bone loss after pediatric hematopoietic cell transplantation,"PETRYK, ANNA",UNIVERSITY OF MINNESOTA,MN,"$477,236"
Pediatric Cancer,2016,NCI,5UG1CA189973-03,,The Florida Pediatric NCORP,"SALMAN, EMAD",FLORIDA ASSN OF PEDIATRIC TUMOR PROG,FL,"$505,000"
Pediatric Cancer,2016,NINDS,5R01NS088283-03,,Role of EZH2 in Medulloblastoma Tumorigenesis,"VIBHAKAR, RAJEEV",UNIVERSITY OF COLORADO DENVER,CO,"$340,156"
Pediatric Cancer,2016,NIGMS,1F31GM116569-01A1,,Developing an Artemis Nuclease Inhibitor to Potentially Treat Acute Lymphoblastic Leukemia,"ESGUERRA, ZITADEL ANNE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$42,218"
Pediatric Cancer,2016,NCI,5R01CA036401-33,,Pharmacogenomics of Childhood Leukemia ALL,"EVANS, WILLIAM",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$726,561"
Pediatric Cancer,2016,NHLBI,5R01HL079571-12,,A Vital tool for the Study of DBA: The Diamond Blackfan Anemia Registry,"LIPTON, JEFFREY",FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH,NY,"$420,957"
Pediatric Cancer,2016,NCI,5F31CA192822-02,,Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia,"SMITH, RUSSELL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$43,576"
Pediatric Cancer,2016,NCI,5R21CA188968-02,,Translocations And Their Widespread Impact on Gene Regulation,"SKOK, JANE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$183,950"
Pediatric Cancer,2016,NCI,5R01CA193651-02,,Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL,"GUTIERREZ, ALEJANDRO",CHILDREN'S HOSPITAL CORPORATION,MA,"$451,095"
Pediatric Cancer,2016,NCI,5R01CA196604-02,,Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia,"CHIANG, MARK",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Pediatric Cancer,2016,NCI,5R01CA102031-11,,Pharmacological modulation of epigenetic changes in AML,"MARCUCCI, GUIDO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$342,107"
Pediatric Cancer,2016,NCI,5R35CA197078-02,,Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome,"SONDEL, PAUL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$917,625"
Pediatric Cancer,2016,NCI,5UG1CA189955-03,,COG NCORP Research Base,"POLLOCK, BRAD",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$3,231,233"
Pediatric Cancer,2016,NCI,5UG1CA189855-03,,South Texas Pediatric NCI Community Oncology Research Program (NCORP),"LANGEVIN, ANNE-MARIE",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$784,554"
Pediatric Cancer,2016,NCI,7R01CA176745-06,,Targeting to Epigenetic Modications in ALL,"ARMSTRONG, SCOTT",DANA-FARBER CANCER INST,MA,"$402,250"
Pediatric Cancer,2016,NCI,5R01CA187397-03,,Exercise and QUality diet After Leukemia,"TONOREZOS, EMILY",SLOAN-KETTERING INST CAN RESEARCH,NY,"$675,314"
Pediatric Cancer,2016,NCI,5UG1CA189817-03,,Bay Area Tumor Institute NCORP,"BAILEY, LISA",BAY AREA TUMOR INSTITUTE,CA,"$730,000"
Pediatric Cancer,2016,NCI,1R01CA206210-01,,Therapeutic targeting of glutamine metabolism in MDS,"KONOPLEVA, MARINA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$506,879"
Pediatric Cancer,2016,NCI,4R01CA166835-05,,Targeting p300 and lysine acetylation in AML,"NIMER, STEPHEN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$317,475"
Pediatric Cancer,2016,NCI,4UM1CA097452-15,,Pediatric Phase 1/Pilot Consortium,"WEIGEL, BRENDA",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$3,181,202"
Pediatric Cancer,2016,NCI,5U01CA199000-02,,Pediatric Preclinical Testing Consortium - Leukemia,"LOCK, RICHARD",UNIVERSITY OF NEW SOUTH WALES,AUSTRA,"$385,674"
Pediatric Cancer,2016,NCI,5R21CA197344-03,,Adaptation of A Prevention-Treatment (ADAPT) Program: Reducing Cancer Risk for Families with Young Children,"BARKIN, SHARI",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$206,190"
Pediatric Cancer,2016,NCI,5P30CA125123-10,8013,Cancer Cell and Gene Therapy Program (Project-005),"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$43,684"
Pediatric Cancer,2016,NCI,5P30CA125123-10,8015,Pediatric Cancer Program (Project-007),"POPLACK, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$43,684"
Pediatric Cancer,2016,NIAMS,4R01AR054447-09,,The Osteoblast as a Determinant of Leukemogenesis,"KOUSTENI, STAVROULA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$341,711"
Pediatric Cancer,2016,NCI,4T32CA009351-38,,Pediatric Oncology Research Training Program,"BERNSTEIN, IRWIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$248,472"
Pediatric Cancer,2016,NCI,5R35CA197697-02,,Mechanisms of regulation by RNA in acute myeloid leukemia,"TENEN, DANIEL",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$1,042,185"
Pediatric Cancer,2016,NCI,4R01CA157460-05,,Nonadherence: Undermining health outcomes in pediatric HSCT?,"PAI, AHNA",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$407,809"
Pediatric Cancer,2016,NCI,5R01CA190957-02,,MYC-dependent loss of splicing fidelity in Glioblastoma multiforme,"PADDISON, PATRICK",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$471,895"
Pediatric Cancer,2016,NCI,5UG1CA189812-03,,Essentia Health Community Cancer Research Program NCORP,"FRIDAY, BRET",ESSENTIA INSTITUTE OF RURAL HEALTH,MN,"$630,000"
Pediatric Cancer,2016,NCI,1R21CA190196-01A1,,Imaging Tumor Associated Macrophages in Bone Sarcomas,"DALDRUP-LINK, HEIKE",STANFORD UNIVERSITY,CA,"$171,839"
Pediatric Cancer,2016,NCI,5R01CA187903-02,,CHARACTERIZATION OF THE MOLECULAR INTERPLAY BETWEEN HOXA9 AND OGT IN ACUTE LEUKEMIA,"RUAL, JEAN-FRANCOIS",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Pediatric Cancer,2016,NIDDK,5K08DK100661-03,,Mechanisms of gastric mucosal response to H. pylori infection at acidic pH,"MARCUS, ELIZABETH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$152,388"
Pediatric Cancer,2016,NIAMS,5K08AR063165-06,,Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.,"CHEN, ELEANOR",UNIVERSITY OF WASHINGTON,WA,"$167,400"
Pediatric Cancer,2016,NIAID,4R01AI038339-20,,Transcriptional Regulation of Innate-Like T Cells,"BENDELAC, ALBERT",UNIVERSITY OF CHICAGO,IL,"$447,050"
Pediatric Cancer,2016,NCI,4P01CA120964-10,7585,Pathology and Translational Research,"WU, CHIN-LEE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$147,549"
Pediatric Cancer,2016,NCI,5UG1CA189816-03,,Iowa-Wide Oncology Research Coalition (I-WORC),"BEHRENS, ROBERT",IOWA ONCOLOGY RESEARCH ASSOCIATION,IA,"$630,000"
Pediatric Cancer,2016,NHLBI,1F31HL132420-01,,Aberrant Ubiquitin-Editing in the Pathogenesis of Myeloid Malignancies,"SMITH, MOLLY",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$36,557"
Pediatric Cancer,2016,NCI,5K01CA186943-02,,Childhood Infection and Pubertal Timing,"MCDONALD, JASMINE",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$139,358"
Pediatric Cancer,2016,NCI,5R03CA198630-02,,Myelodysplastic Syndrome Target Identification and Validation,"CHERIYATH, VENUGOPALAN",TEXAS A&M UNIVERSITY-COMMERCE,TX,"$79,700"
Pediatric Cancer,2016,NEI,5K23EY022673-06,,Visual outcome measures in children with optic Pathway gliomas,"AVERY, ROBERT",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$228,593"
Pediatric Cancer,2016,NCI,5K08CA188529-03,,Genomic profiling and development of murine models of transformation of MPNs,"RAMPAL, RAAJIT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$178,200"
Pediatric Cancer,2016,NINR,5R01NR015458-02,,Building Evidence for Effective Palliative/End of Life Care for Teens with Cancer,"LYON, MAUREEN",CHILDREN'S RESEARCH INSTITUTE,DC,"$639,428"
Pediatric Cancer,2016,NCI,1F31CA206338-01,,Myc transcriptional regulation in T-ALL,"FORSYTH, KATHERINE",UNIVERSITY OF PENNSYLVANIA,PA,"$43,576"
Pediatric Cancer,2016,NCI,1F30CA196095-01A1,,The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis,"MCAULEY, JAMES",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$48,576"
Pediatric Cancer,2016,NCI,4K01CA154758-05,,MYCN-induced calcium and magnesium signaling regulates Neuroblastoma progression,"KOOMOA, DANA-LYNN",UNIVERSITY OF HAWAII AT HILO,HI,"$134,922"
Pediatric Cancer,2016,NCI,5T32CA136432-08,,Research Training in Pediatric Oncology,"ORKIN, STUART",DANA-FARBER CANCER INST,MA,"$471,493"
Pediatric Cancer,2016,NCI,4P50CA100632-14,,SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,"KANTARJIAN, HAGOP",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$2,161,999"
Pediatric Cancer,2016,NCI,4K07CA178100-04,,A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors,"HOCKING, MATTHEW",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$130,495"
Pediatric Cancer,2016,NCI,5R01CA194473-02,,(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors,"GRAMATGES, MARIA",BAYLOR COLLEGE OF MEDICINE,TX,"$496,121"
Pediatric Cancer,2016,NINDS,5R01NS086956-03,,Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma,"VIBHAKAR, RAJEEV",UNIVERSITY OF COLORADO DENVER,CO,"$346,576"
Pediatric Cancer,2016,NCI,1F30CA206386-01,,Convection-enhanced Delivery of Radiosensitizer-Encapsulating Nanoparticles for the Treatment of Pediatric Brainstem Gliomas,"KING, AMANDA",YALE UNIVERSITY,CT,"$28,224"
Pediatric Cancer,2016,NCI,1F32CA206418-01,,Epigenetic Mechanisms of Oncohistone Detoxification,"DIEHL, KATHARINE",PRINCETON UNIVERSITY,NJ,"$52,542"
Pediatric Cancer,2016,NCI,5K08CA187577-03,,Investigating Resistance to FLT3 Inhibitors in AML,"SMITH, CATHERINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$175,808"
Pediatric Cancer,2016,NCI,4K08CA177927-04,,Exploring Sarcoma Metastatic Potential,"WEISS, KURT",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$165,456"
Pediatric Cancer,2016,NCI,5P50CA190991-03,5453,Administrative Core,"SAMPSON, JOHN",DUKE UNIVERSITY,NC,"$198,101"
Pediatric Cancer,2016,NCI,5R01CA189299-02,,Cytokine- and Satellite Cell-mediated Muscle Disease Promotion,"KELLER, CHARLES",CHILDREN'S CANCER THERAPY DEVELOP/INST,OR,"$322,447"
Pediatric Cancer,2016,NINDS,1R01NS096954-01,,Novel K27M Mutation-derived Neoantigen for T Cell Therapy in Gliomas,"OKADA, HIDEHO","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$346,719"
Pediatric Cancer,2016,NCI,4R25CA160013-05,,Promoting Healthy Cancer Survivorship in Rural Colorado Primary Health Care Pract,"OVERHOLSER, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$299,836"
Pediatric Cancer,2016,NCI,1R13CA206376-01,,New Frontiers in Pediatric Stem Cell Transplantation,"JACOBSOHN, DAVID",CHILDREN'S RESEARCH INSTITUTE,DC,"$5,000"
Pediatric Cancer,2016,NHLBI,1R13CA206376-01,,New Frontiers in Pediatric Stem Cell Transplantation,"JACOBSOHN, DAVID",CHILDREN'S RESEARCH INSTITUTE,DC,"$7,500"
Pediatric Cancer,2016,NCI,5R35CA197561-02,,Molecular Pathogenesis of Acute Myeloid Leukemia,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$915,000"
Pediatric Cancer,2016,NCI,5R21CA177457-03,,Preservation of Dried Plasma Spots for downstream proteomic applications,"PETRITIS, KONSTANTINOS",PHOENIX CHILDREN'S HOSPITAL,AZ,"$169,148"
Pediatric Cancer,2016,NCI,5F31CA189452-03,,Tumor Suppressor RASSF2 in t(8;21) Acute Myeloid Leukemia,"STONER, SAMUEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$35,243"
Pediatric Cancer,2016,NCI,4P30CA082103-18,6393,Pediatric Malignancies,"MCCORMICK, FRANK","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$163
Pediatric Cancer,2016,NCI,5R01CA180279-03,,Three-dimensional Model of Human Ewing Sarcoma,"MIKOS, ANTONIOS",RICE UNIVERSITY,TX,"$322,736"
Pediatric Cancer,2016,NCI,5UG1CA189958-03,,Nemours NCI Community Oncology Research Program (NCORP),"SANDLER, ERIC",ALFRED I. DU PONT HOSP FOR CHILDREN,DE,"$992,500"
Pediatric Cancer,2016,NCI,4T32CA128583-10,,Research Training in Childhood Cancer,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$292,319"
Pediatric Cancer,2016,NCI,5R01CA175737-03,,Perinatal immune development and risk of childhood acute lymphoblastic leukemia,"WIEMELS, JOSEPH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$618,506"
Pediatric Cancer,2016,NCI,4U54CA168512-05,7065,Investigating G-protein coupled receptors (GPCRs) as biomarkers of aggressive,"LAWLOR, ELIZABETH",UNIVERSITY OF MICHIGAN,MI,"$236,053"
Pediatric Cancer,2016,NCI,4U54CA168512-05,7126,Tissue and Pathology Resources,"CZERNIAK, BOGDAN",SARC,MI,"$272,690"
Pediatric Cancer,2016,NCI,4U54CA168512-05,7127,Clinical Trials,"BAKER, LAURENCE",UNIVERSITY OF MICHIGAN,MI,"$172,299"
Pediatric Cancer,2016,NCI,4U54CA168512-05,7130,Developmental Research Program,"REINKE, DENISE",SARC,MI,"$156,714"
Pediatric Cancer,2016,NCI,4U54CA168512-05,7131,Career Development Program,"REINKE, DENISE",SARC,MI,"$164,779"
Pediatric Cancer,2016,NCI,5R01CA178908-03,,Integrated models for metastatic phenotype and outcome prediction in osteosarcoma,"SPENTZOS, DIMITRIOS",MASSACHUSETTS GENERAL HOSPITAL,MA,"$356,299"
Pediatric Cancer,2016,NCI,4R01CA163394-04,,Impact of chlorhexidine bathing on reducing infections in children with cancer,"ZERR, DANIELLE",SEATTLE CHILDREN'S HOSPITAL,WA,"$542,687"
Pediatric Cancer,2016,NCI,4K08CA154975-05,,The role of Hedgehog/Gli in normal hematopoiesis and leukemia,"MERCHANT, AKIL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$175,824"
Pediatric Cancer,2016,NCI,4K08CA169055-05,,Genetic and epigenetic basis of relapse in acute myeloid leukemia,"GARRETT-BAKELMAN, FRANCINE",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$148,320"
Pediatric Cancer,2016,NCI,5R01CA136551-08,,Targeted therapy of B cell malignances with CAR-T cells of defined composition,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$560,424"
Pediatric Cancer,2016,NCI,4P50CA097257-14,7009,BRAIN TUMOR SPORT GRANT,"WIENCKE, JOHN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$189,751"
Pediatric Cancer,2016,NCI,4P50CA097257-14,7011,NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES,"JAMES, CHARLES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$233,456"
Pediatric Cancer,2016,NINDS,5K02NS086917-03,,Functional Dissection of the K27M Histone Mutation in Vivo,"BECHER, OREN",DUKE UNIVERSITY,NC,"$144,953"
Pediatric Cancer,2016,NCI,5UG1CA189862-03,,Puerto Rico NCI Community Oncology Research Program Minority/Underserved,"BAEZ, LUIS",COMPREHENSIVE CANCER CENTER/ UNIV/PR,PR,"$609,407"
Pediatric Cancer,2016,NCI,5P01CA078902-18,5394,Project 2: Stem Cell Allografts for Acute Leukemia and Myelodysplasia,"SANDMAIER, BRENDA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$239,833"
Pediatric Cancer,2016,NCI,5R01CA157823-05,,Genetic Susceptibility and Biomarkers of Platinum-related Toxicities,"TRAVIS, LOIS",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,$1
Pediatric Cancer,2016,NCI,5R01CA188314-02,,Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor,"GROHAR, PATRICK",VAN ANDEL RESEARCH INSTITUTE,MI,"$434,625"
Pediatric Cancer,2016,NCI,5R01CA192662-02,,Methylation and mutations in RB1 and variants of synthetic folic acid metabolism,"ORJUELA, MANUELA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$515,071"
Pediatric Cancer,2016,NIEHS,5P50ES018172-07,5328,Core A - Administrative Core,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$187,961"
Pediatric Cancer,2016,NIEHS,5P50ES018172-07,5329,"Project 1 - In Utero Chemical Exposures, Immune Status, and Childhood Leukemia","METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$181,287"
Pediatric Cancer,2016,NIEHS,5P50ES018172-07,5330,Project 2 - Identifying In Utero Exposures that are Risk Factors for Childhood Leukemia,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$171,522"
Pediatric Cancer,2016,NIEHS,5P50ES018172-07,5331,"Project 3 - Prenatal Exposures, Constitutive Genetics, DNA Methylation & Childhood Leukemia","WIEMELS, JOSEPH",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$156,321"
Pediatric Cancer,2016,NIEHS,5P50ES018172-07,5332,Core B - Community Outreach and Translation Core,"MILLER, MARK",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$90,999"
Pediatric Cancer,2016,NIEHS,5P50ES018172-07,5333,Core C - Mouse Model Service Core,"KOGAN, SCOTT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$62,910"
Pediatric Cancer,2016,NCI,5R00CA178189-04,,Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk Neuroblastoma,"ZHU, SHIZHEN",MAYO CLINIC ROCHESTER,MN,"$249,000"
Pediatric Cancer,2016,NCI,1R41CA203457-01A1,,Nanoparticle Delivery System for Ewing Sarcoma Treatment,"NAGY, JON","NANOVALENT PHARMACEUTICALS, INC.",MT,"$240,750"
Pediatric Cancer,2016,NCI,5R01CA194189-02,,Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations,"WIEMELS, JOSEPH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$986,792"
Pediatric Cancer,2016,NCI,5P01CA196539-02,7962,Core 1: Administrative,"ALLIS, CHARLES",ROCKEFELLER UNIVERSITY,NY,"$119,788"
Pediatric Cancer,2016,NCI,5P01CA196539-02,7963,Core 2: Genomics/Epigenomics Sequencing Core,"MAJEWSKI, JACEK",MCGILL UNIVERSITY,CANADA,"$349,222"
Pediatric Cancer,2016,NCI,5P01CA196539-02,7964,Core 3: Quantitative Proteomics Core,"GARCIA, BENJAMIN",UNIVERSITY OF PENNSYLVANIA,PA,"$373,477"
Pediatric Cancer,2016,NCI,5P01CA196539-02,7965,Project 1: Decoding Origin and Modeling Oncohistones in Pediatric Cancers,"JABADO, NADA",MCGILL UNIVERSITY HEALTH CTR RES INST,CANADA,"$282,942"
Pediatric Cancer,2016,NCI,5P01CA196539-02,7966,Project 2:Elucidating Mechanisms of Chromatin Dysregulation by Oncohistones,"ALLIS, CHARLES",ROCKEFELLER UNIVERSITY,NY,"$387,793"
Pediatric Cancer,2016,NCI,5P01CA196539-02,7967,Project 3: Mechanisms of Methyltransferase Dysregulation by Oncohistones,"MUIR, TOM",PRINCETON UNIVERSITY,NJ,"$341,895"
Pediatric Cancer,2016,NCI,5P01CA066996-18,7123,Mitochondrial determination of response to targeted AML therapies,"LETAI, ANTHONY",DANA-FARBER CANCER INST,MA,"$368,774"
Pediatric Cancer,2016,NCI,5P01CA066996-18,7124,Determination of the mechanism of lenalidomide activity in acute myeloid leukemia,"EBERT, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$327,877"
Pediatric Cancer,2016,NCI,5P01CA066996-18,7126,Novel Epigenetic Approaches in AML,"BRADNER, JAMES",DANA-FARBER CANCER INST,MA,"$471,092"
Pediatric Cancer,2016,NCI,4R01CA168699-04,,Pharmacokinetics and pharmacogenomics for 13-cis retinoic acid in neuroblastoma,"KANG, MIN",TEXAS TECH UNIVERSITY HEALTH SCIS CENTER,TX,"$284,060"
Pediatric Cancer,2016,NINDS,5R01NS093079-02,,Targeting histone demethylase activity for the treatment of pediatric brainstem glioma,"HASHIZUME, RINTARO",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$309,000"
Pediatric Cancer,2016,NCI,5R01CA180519-03,,Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,"WANG, BINGHE",GEORGIA STATE UNIVERSITY,GA,"$442,311"
Pediatric Cancer,2016,NCI,5R35CA197743-02,,Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment,"JAIN, RAKESH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$1,044,000"
Pediatric Cancer,2016,NCI,5P01CA165995-04,7124,NF-KB REGULATION OF A METABOLIC SHIFT IN CHILDHOOD SARCOMAS,"GUTTRIDGE, DENIS",OHIO STATE UNIVERSITY,OH,"$310,628"
Pediatric Cancer,2016,NCI,5P01CA165995-04,7125,THE ROLE OF STAT3 SIGNALING IN CHILDHOOD SARCOMAS,"LIN, JIAYUH",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$332,396"
Pediatric Cancer,2016,NCI,5P01CA165995-04,7126,INSULIN-LIKE GROWTH FACTOR SIGNALING AS A THERAPEUTIC TARGET IN CHILDHOOD SARCOMAS,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$277,840"
Pediatric Cancer,2016,NCI,5P01CA165995-04,7127,ADMINISTRATIVE AND BIOSTATISTICS CORE,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$198,151"
Pediatric Cancer,2016,NCI,5P01CA165995-04,7128,XENOGRAFT AND CELL LINE CORE,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$251,757"
Pediatric Cancer,2016,NCI,5P01CA165995-04,7129,COMPARTIVE ANIMAL CORE,"LONDON, CHERYL",OHIO STATE UNIVERSITY,OH,"$246,330"
Pediatric Cancer,2016,NHLBI,7R01HL128173-02,,Multiscale Modeling of Myelodysplastic Syndromes,"COREY, SETH",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$749,005"
Pediatric Cancer,2016,NCI,5R21CA187226-02,,Markers of Cognitive Decline During Treatment for Childhood ALL,"COLE, PETER","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$215,938"
Pediatric Cancer,2016,NIEHS,5U01ES026122-02,,Pregnancy and Prenatal PAHs and other Environmental Exposures and Breast Cancer,"TERRY, MARY BETH",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$907,851"
Pediatric Cancer,2016,NINR,5F31NR015951-02,,Treatment Decision Making Involvement in Adolescents and Young Adults with Cancer,"PYKE-GRIMM, KIMBERLY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,027"
Pediatric Cancer,2016,NCI,5P01CA171983-04,7611,Targeting Ceramide Metabolism in AML,"KESTER, MARK",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$300,315"
Pediatric Cancer,2016,NCI,5P01CA171983-04,7612,Targeting Acid Ceramidase in AML,"LOUGHRAN, THOMAS",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$319,896"
Pediatric Cancer,2016,NCI,5P01CA171983-04,7613,Targeting Sphingosine Kinase in AML,"WANG, HONG-GANG",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$224,096"
Pediatric Cancer,2016,NCI,5P01CA171983-04,7616,Targeted Sphing''omics'' Core,"FOX, TODD",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$136,170"
Pediatric Cancer,2016,NCI,5P01CA171983-04,7411,Animal Modeling and Clinical Resources Core,"CLAXTON, DAVID",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$340,284"
Pediatric Cancer,2016,NIDCR,5DP5OD021403-02,,Cohesin gene mutations in tumorigenesis,"SOLOMON, DAVID","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$1
Pediatric Cancer,2016,RMAP,5DP5OD021403-02,,Cohesin gene mutations in tumorigenesis,"SOLOMON, DAVID","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$396,249"
Pediatric Cancer,2016,NINDS,5R21NS091682-02,,Targeted delivery of a sonic hedgehog inhibitor for the study of medulloblastoma therapeutics,"KIM, YONGTAE",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$185,019"
Pediatric Cancer,2016,NINDS,5R01NS091620-02,,Precision Medicine For Pediatric Low-Grade Gliomas,"HAAS-KOGAN, DAPHNE",DANA-FARBER CANCER INST,MA,"$521,946"
Pediatric Cancer,2016,NCI,5R01CA138744-07,,Tyrosine kinase inhibitors for the treatment of childhood AML,"BAKER, SHARYN",OHIO STATE UNIVERSITY,OH,"$343,388"
Pediatric Cancer,2016,RMAP,5K01ES026842-02,,Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia,"PAGUIRIGAN, AMY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$119,535"
Pediatric Cancer,2016,NCI,5K01CA188151-02,,Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML,"OROZCO, JOHNNIE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$169,020"
Pediatric Cancer,2016,NCI,5K08CA193982-02,,The Interaction of Autophagy and BRAF Mutations in Brain Tumors,"MULCAHY LEVY, JEAN",UNIVERSITY OF COLORADO DENVER,CO,"$164,393"
Pediatric Cancer,2016,NCI,5R01CA197137-02,,Early Phase Clinical Trials in Imaging and Image-Guided Interventions,"KIM, AERANG",CHILDREN'S RESEARCH INSTITUTE,DC,"$264,708"
Pediatric Cancer,2016,NHLBI,2P01HL048546-21A1,8683,Preclinical evaluation of small molecules with proven benefit in FA animal models,"GROMPE, MARKUS",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$323,785"
Pediatric Cancer,2016,NCI,2P30CA093373-14,8697,Clinical Protocol and Data Management,"KELLY, KAREN",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$282,197"
Pediatric Cancer,2016,NINDS,5R21NS095650-02,,Focus on Dicer inhibition as a novel treatment for brain tumors,"DESHMUKH, MOHANISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$190,000"
Pediatric Cancer,2016,NCI,5P30CA196521-02,7057,Clinical Protocol and Data Management/Clinical Trials Office (Core-007),"POSNER, MARSHALL",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$164,990"
Pediatric Cancer,2016,NCI,5P01CA084203-12,5337,Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,"MAYTIN, EDWARD",MASSACHUSETTS GENERAL HOSPITAL,MA,"$179,777"
Pediatric Cancer,2016,NCI,5P01CA096832-12,6145,Molecular Pathogenesis of Pediatric High Grade Glioma,"BAKER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$477,235"
Pediatric Cancer,2016,NCI,5P01CA096832-12,6146,The DNA Damage Response and Tumorigenesis in the Brain,"MCKINNON, PETER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$440,815"
Pediatric Cancer,2016,NCI,5P01CA096832-12,6147,Collaborating Mutations in Medulloblastoma,"ROUSSEL (SHERR), MARTINE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$442,973"
Pediatric Cancer,2016,NCI,5P01CA096832-12,6148,Cellular and Molecular Origins of Medulloblastoma Subgroups,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$443,549"
Pediatric Cancer,2016,NCI,5P01CA096832-12,8857,Core B,"BAKER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$155,684"
Pediatric Cancer,2016,NCI,5U54CA196519-02,7037,Core B: Biospecimen/Pathology Core,"FOROUD, TATIANA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$110,721"
Pediatric Cancer,2016,NCI,5U54CA196519-02,7041,Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$408,012"
Pediatric Cancer,2016,NCI,5U54CA196519-02,7042,Project 4: Secondary Cancers Among NF1 Cancer Survivors,"NAKAMURA, JEAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$492,187"
Pediatric Cancer,2016,NCI,2R25CA142519-06,,Enriching Communication Skills for Health Professionals in Oncofertility (ECHO),"QUINN, GWENDOLYN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$252,552"
Pediatric Cancer,2016,NIBIB,2P41EB015909-16,5061,TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.,"VAN ZIJL, PETER",HUGO W. MOSER RES INST KENNEDY KRIEGER,MD,"$182,592"
Pediatric Cancer,2016,NCI,5P30CA042014-27,5852,Clinical Protocol and Data Management,"AKERLEY, WALLACE",UNIVERSITY OF UTAH,UT,"$227,746"
Pediatric Cancer,2016,NIGMS,2P20GM103548-06,5159,Exploring the origins of childhood leukemia: investigating transcriptional networks in hematopoiesis and acute leukemia,"MILANOVICH, SAMUEL",SANFORD RESEARCH/USD,SD,"$299,267"
Pediatric Cancer,2016,NINDS,5R01NS095411-02,,Targeting Tumors with NF1 Loss,"SANCHEZ, YOLANDA",DARTMOUTH COLLEGE,NH,"$547,736"
Pediatric Cancer,2016,NCI,5R42CA168107-03,,Using game mechanics to improve outcomes among stem cell transplant survivors,"MCLAUGHLIN, JEFFERY","RADIANT CREATIVE GROUP, LLC",TX,"$344,638"
Pediatric Cancer,2016,NCI,5U01DK108334-02,,INSPPIRE to Study Pediatric Chronic Pancreatitis,"UC, ALIYE",UNIVERSITY OF IOWA,IA,"$190,000"
Pediatric Cancer,2016,NIDDK,5U01DK108334-02,,INSPPIRE to Study Pediatric Chronic Pancreatitis,"UC, ALIYE",UNIVERSITY OF IOWA,IA,"$262,082"
Pediatric Cancer,2016,NCI,5U24DA041123-02,,ABCD-USA Consortium: Data Analysis Center,"DALE, ANDERS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$750,000"
Pediatric Cancer,2016,NIDA,5U24DA041123-02,,ABCD-USA Consortium: Data Analysis Center,"DALE, ANDERS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$2,014,270"
Pediatric Cancer,2016,NCI,5R00CA188293-03,,Exploring a new therapeutic approach through targeting epigenetic enzymes in ALL,"NTZIACHRISTOS, PANAGIOTIS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$249,000"
Pediatric Cancer,2016,NCI,4R00CA181500-03,,The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development,"BLACKBURN, JESSICA",UNIVERSITY OF KENTUCKY,KY,"$249,000"
Pediatric Cancer,2016,NCI,5U54CA193419-02,7381,Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer,"LICHT, JONATHAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$542,300"
Pediatric Cancer,2016,NCI,2T32CA009659-21A1,,Training Physician Scientists in Pediatric Oncology,"DECLERCK, YVES",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$64,768"
Pediatric Cancer,2016,NCI,5R00CA184411-04,,Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,"LI, LING",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$248,999"
Pediatric Cancer,2016,NCI,5U54CA193461-02,7298,Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia,"SCADDEN, DAVID",MASSACHUSETTS GENERAL HOSPITAL,MA,"$543,982"
Pediatric Cancer,2016,NCI,5P30CA068485-21,7796,Cancer Health Outcomes and Control Research Program (CO) (Project-007),"FRIEDMAN, DEBRA",VANDERBILT UNIVERSITY,TN,"$84,561"
Pediatric Cancer,2016,NINDS,1R01NS097271-01,,Deconstruct tumor microenvironment in medulloblastoma,"ZONG, HUI",UNIVERSITY OF VIRGINIA,VA,"$376,260"
Pediatric Cancer,2016,NCI,1R01CA207217-01,,Exploring oncogenic translation programs in cancer,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$406,648"
Pediatric Cancer,2016,NCI,1R01CA207530-01,,The Role of LMO2 in the Pathogenesis of T-cell Leukemia,"DAVE, UTPAL",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$362,066"
Pediatric Cancer,2016,NCI,1R01CA208405-01,,Modeling pediatric glioma in human ES cells:mechanistic and therapeutic insights,"TABAR, VIVIANE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$407,761"
Pediatric Cancer,2016,NINDS,1K08NS097624-01,,Investigation of Histone H3 Post-Translational Modifications in Pediatric Brainstem Glioma,"SARATSIS, AMANDA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$181,983"
Pediatric Cancer,2016,NIDDK,1K08DK111234-01,,Identifying Barriers and Facilitators to the Implementation of Radiation-Free Imaging Protocols in the Emergency Department,"REPPLINGER, MICHAEL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$162,788"
Pediatric Cancer,2016,NIGMS,1R01GM120607-01,,Genomic profiling of pathological R-loop formation in human diseases.,"CHEDIN, FREDERIC",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$314,000"
Pediatric Cancer,2016,NCI,1R21CA198641-01A1,,New methods to address dilemmas in mixed recurrent-event and panel-count data,"ZHU, LIANG",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$240,361"
Pediatric Cancer,2016,NCI,1R01CA214146-01A1,,DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA,"GUTMANN, DAVID",WASHINGTON UNIVERSITY,MO,"$348,844"
Pediatric Cancer,2016,NCI,1R21CA208529-01,,(PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach,"MODIANO, JAIME",UNIVERSITY OF MINNESOTA,MN,"$198,578"
Pediatric Cancer,2016,NCI,1R03CA186176-01A1,,Targeting high fat diet-driven DNA hypermethylation for AML chemoprevention,"LIU, SHUJUN",UNIVERSITY OF MINNESOTA,MN,"$77,500"
Pediatric Cancer,2016,NINDS,5F31NS093986-02,,The role of H3K27M-induced aberrant PRC2 activity in brainstem gliomagenesis,"CORDERO, FRANCISCO",DUKE UNIVERSITY,NC,"$33,498"
Pediatric Cancer,2016,NCI,9R01CA210165-41A1,,Targeting of Genes in the Mammalian Genome,"CAPECCHI, MARIO",UNIVERSITY OF UTAH,UT,"$468,711"
Pediatric Cancer,2016,NCI,1R01CA197313-01A1,,Functional Dissection of the K27M Histone Mutation In Gliomagenesis,"BECHER, OREN",DUKE UNIVERSITY,NC,"$363,713"
Pediatric Cancer,2016,NCI,1R01CA201069-01A1,,Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia,"OPFERMAN, JOSEPH",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$410,606"
Pediatric Cancer,2016,NCI,1R01CA196658-01A1,,A rapid spontaneous murine model of CN-AML,"GRIMES, H.",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$625,379"
Pediatric Cancer,2016,NHLBI,1R01HL130995-01A1,,Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment,"QU, CHENG-KUI",EMORY UNIVERSITY,GA,"$390,000"
Pediatric Cancer,2016,NCI,3U01HG006485-04S1,,Incorporation of Genomic Sequencing into Pediatric Cancer Care,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$100,000"
Pediatric Cancer,2016,NHGRI,3U01HG006485-04S1,,Incorporation of Genomic Sequencing into Pediatric Cancer Care,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$1,052,619"
Pediatric Cancer,2016,NCI,1R01CA193478-01A1,,Web-based Physical Activity Intervention for Children with ALL,"NESS, KIRSTEN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$937,623"
Pediatric Cancer,2016,NCI,1R01CA200574-01A1,,Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis,"ZHANG, LIANGFANG",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$372,888"
Pediatric Cancer,2016,NHLBI,1R01HL130937-01A1,,Genetic characterization of osteoblast-induced leukemias,"KOUSTENI, STAVROULA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$585,485"
Pediatric Cancer,2016,NCI,1R01CA201788-01A1,,Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer,"POLLOCK, BRAD",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$699,411"
Pediatric Cancer,2016,NCI,1R01CA201444-01A1,,Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment,"MITTELMAN, STEVEN",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$413,948"
Pediatric Cancer,2016,NCI,1R21CA201831-01A1,,SFK-inhibitor enhancement of ATRA-mediated differentiation of APL,"REDNER, ROBERT",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$200,970"
Pediatric Cancer,2016,NCI,1R21CA202296-01A1,,HSC-Independent Mechanisms Underlying JMML,"CHAN, REBECCA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$169,650"
Pediatric Cancer,2016,NCI,1R21CA198430-01A1,,Altered mitochondria-ER signaling as a cause of chemotherapy resistance,"HOGARTY, MICHAEL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$193,314"
Pediatric Cancer,2016,NCI,1R21CA209229-01,,Mechanism of Ikaros Tumor Suppression in progenitor B cell leukemia,"SCHJERVEN, HILDE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$235,196"
Pediatric Cancer,2016,NCI,1R21CA198042-01A1,,Follow-up care and preventive service use among survivors of adolescent and young adult cancer.,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$217,666"
Pediatric Cancer,2016,NCI,1R21CA201809-01A1,,Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression,"FORD, HEIDE",UNIVERSITY OF COLORADO DENVER,CO,"$169,106"
Pediatric Cancer,2016,NCI,1R21CA209304-01,,Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases,"GREENFIELD, EDWARD",CASE WESTERN RESERVE UNIVERSITY,OH,"$172,369"
Pediatric Cancer,2016,NCI,1R21CA202390-01A1,,PRMT1-mediated metabolic reprogramming in leukemia progression,"ZHAO, XINYANG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$159,863"
Pediatric Cancer,2016,NCI,1R21CA201775-01A1,,Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL),"PARAMESWARAN, RESHMI",CASE WESTERN RESERVE UNIVERSITY,OH,"$206,843"
Pediatric Cancer,2016,NINDS,1R21NS094654-01A1,,TMEM108 IS A NOVEL TARGET IN NEUROBLASTOMA,"YANG, JIANHUA",BAYLOR COLLEGE OF MEDICINE,TX,"$198,125"
Pediatric Cancer,2016,NCI,1R21CA202488-01A1,,Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia,"SWORDS, RONAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$200,318"
Pediatric Cancer,2016,NCI,1R21CA202485-01A1,,A novel oncogenic driver in Ewing sarcoma,"SHIIO, YUZURU",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$199,013"
Pediatric Cancer,2016,NCI,1K99CA201592-01A1,,Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma,"BANDOPADHAYAY, PRATITI",DANA-FARBER CANCER INST,MA,"$151,039"
Pediatric Cancer,2016,NCI,1K08CA201638-01A1,,Elucidating and exploiting the mechanisms by which IL-6 and IL-8 facilitate osteosarcoma metastasis,"ROBERTS, RYAN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$163,080"
Pediatric Cancer,2016,NINDS,1R21NS095273-01A1,,Modulating the Nucleopathy caused by FUS Mutants of ALS,"HAYWARD, LAWRENCE",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$251,250"
Pediatric Cancer,2016,NCI,1R01CA209829-01,,Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia,"PAYNE, KIMBERLY",LOMA LINDA UNIVERSITY,CA,"$375,047"
Pediatric Cancer,2016,NCI,1R01CA202025-01A1,,Mapping cancer micro-environments for acute leukemia,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$463,557"
Pediatric Cancer,2016,NCI,1R35CA210030-01,,Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer,"STEGMAIER, KIMBERLY",DANA-FARBER CANCER INST,MA,"$1,046,441"
Pediatric Cancer,2016,NINR,1R21NR016580-01,,Barriers to Hospice and Palliative Care Utilization Among Adolescent and Young Adult Cancer Patients Living in Poverty,"MACK, JENNIFER",DANA-FARBER CANCER INST,MA,"$247,428"
Pediatric Cancer,2016,NCI,1U54CA210190-01,5200,Core 2: Cell and Whole Animal Genome Engineering,"LARGAESPADA, DAVID",UNIVERSITY OF MINNESOTA,MN,"$42,598"
Pediatric Cancer,2016,NCI,1U54CA210190-01,5201,Project 1: Physical modeling and dynamics of tumor cell migration mechanics,"ODDE, DAVID",UNIVERSITY OF MINNESOTA,MN,"$565,189"
Pediatric Cancer,2016,NIDDK,1F31DK111058-01,,The role of histone demethylase Kdm6b in normal hematopoiesis,"MALLANEY, CATES",WASHINGTON UNIVERSITY,MO,"$30,183"
Pediatric Cancer,2016,NCI,1R01CA204396-01A1,,Aberrant signaling in acute myeloid leukemia,"KENTSIS, ALEX",SLOAN-KETTERING INST CAN RESEARCH,NY,"$459,674"
Pediatric Cancer,2016,NCI,1F30CA210334-01,,Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG),"SCHUELKE, MATTHEW",MAYO CLINIC ROCHESTER,MN,"$43,776"
Pediatric Cancer,2016,NCI,1F31CA210408-01,,Modeling pediatric gliomas using a human pluripotent stem cell-based platform,"SMITH, RYAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$27,576"
Pediatric Cancer,2016,NCI,1F30CA210465-01,,Identification of chemosensitizing agents that block DNA repair by the Fanconi Anemia/Bloom Dissolvasome complex,"VOTER, ANDREW",UNIVERSITY OF WISCONSIN-MADISON,WI,"$33,483"
Pediatric Cancer,2016,NCI,1F30CA200227-01A1,,Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?,"CERABONA, DONNA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$27,801"
Pediatric Cancer,2016,NCI,1F30CA210518-01,,Evaluation of Brutonâ€™s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML,"DENG, LISA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$36,738"
Pediatric Cancer,2016,NHLBI,1F31HL131140-01A1,,The effects of LUC7L2 on alternative splicing in myelodysplastic syndromes,"HERSHBERGER, COURTNEY",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$37,403"
Pediatric Cancer,2016,NCI,1F31CA206322-01A1,,Mechanism of the methyltransferase Prdm3 in MLL leukemogenesis,"MCGLYNN, KELLY",UNIVERSITY OF ROCHESTER,NY,"$43,576"
Pediatric Cancer,2016,NCI,1F30CA210588-01,,EWS/FLI Regulates Transcriptional Activation in Ewing Sarcoma via Length Dependent GGAA Microsatellites,"JOHNSON, KIRSTEN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$48,576"
Pediatric Cancer,2016,NCI,1R01CA204974-01A1,,Structural Variation in Neuroblastoma,"DISKIN, SHARON",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$384,300"
Pediatric Cancer,2016,NIDDK,1R01DK107286-01A1,,Signaling Pathways in MDS,"SAKAMOTO, KATHLEEN",STANFORD UNIVERSITY,CA,"$363,278"
Pediatric Cancer,2016,NCI,1F31CA210607-01,,Discovery of pathogenic germline variants in pediatric cancers using genomics.,"MADUBATA, CHIOMA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$39,638"
Pediatric Cancer,2016,NINR,5F31NR015393-02,,Parents' Experiences in Pediatric Oncology Phase 1 Clinical Trials,"CRANE, STACEY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$37,511"
Pediatric Cancer,2016,NCI,1F31CA206463-01A1,,Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia,"CONTRERAS-TRUJILLO, HUMBERTO",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$43,009"
Pediatric Cancer,2016,NCI,2R01CA140729-06A1,,Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL),"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$472,074"
Pediatric Cancer,2016,NCI,5F30CA192831-02,,Investigating non-coding mechanisms of functional dysregulation in neuroblastoma,"OLDRIDGE, DEREK",UNIVERSITY OF PENNSYLVANIA,PA,"$30,400"
Pediatric Cancer,2016,NCI,5F30CA200347-02,,Disruption of circadian rhythm in hypoxia,"WALTON, ZANDRA",UNIVERSITY OF PENNSYLVANIA,PA,"$30,400"
Pediatric Cancer,2016,NCI,3P30CA021765-37S1,,Cancer Center Support Grant Year 35 (CCSG),"ROBERTS, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$134,250"
Pediatric Cancer,2016,NCI,1R43CA206666-01A1,,Self-Management and Support for Adolescents and Young Adults with Cancer,"DONOVAN, ELIZABETH","BODIMOJO, INC",MA,"$224,911"
Pediatric Cancer,2016,NCI,2R13CA132568-10,,International Symposium on Juvenile Myelomonocytic Leukemia (JMML),"CHAN, REBECCA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$5,000"
Pediatric Cancer,2016,NHLBI,2R13CA132568-10,,International Symposium on Juvenile Myelomonocytic Leukemia (JMML),"CHAN, REBECCA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$5,000"
Pediatric Cancer,2016,NCI,1R43CA206709-01A1,,Receptor-Targeted Neuroendocrine Tumor Imaging with Generator-Produced Cu-62,"LACY, JEFFREY","PROPORTIONAL TECHNOLOGIES, INC.",TX,"$218,629"
Pediatric Cancer,2016,NCI,261200800001E-96-0-142,,OCG Data Coordinating Center,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$540,000"
Pediatric Cancer,2016,NIGMS,1R43GM121138-01,,Histone phosphorylation-dependent screening platform for identification of inhibitors to treat neuroblastoma,"SUN, ZU-WEN","EPICYPHER, INC.",NC,"$224,326"
Pediatric Cancer,2016,NCI,2P30CA014089-41,5249,Core-007,"GRUBER, STEPHEN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$294,031"
Pediatric Cancer,2016,NCI,2P30CA014089-41,5251,Core-009,"GRUBER, STEPHEN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$335,322"
Pediatric Cancer,2016,NCI,5F31CA192885-02,,The Role of DDX41 in the Spliceosome and Myeloid Neoplasia,"HIZNAY, JAMES",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$52,971"
Pediatric Cancer,2016,NCI,7R01CA181050-03,,KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN,"PULSIPHER, MICHAEL",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$370,071"
Pediatric Cancer,2016,NCI,4R00CA181496-03,,Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,"LEE, DUNG-FANG",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$249,000"
Pediatric Cancer,2016,NCI,3P01CA196539-01S1,,Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers,"ALLIS, CHARLES",ROCKEFELLER UNIVERSITY,NY,"$34,299"
Pediatric Cancer,2016,NCI,1R50CA211428-01,,Histone Modification and Transcription Elongation in Human Cancer,"SMITH, EDWIN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$183,657"
Pediatric Cancer,2016,NCI,1R50CA211466-01,,BM NICHE DISRUPTION AND IMMUNOTHERAPY IN HEMATOLOGICAL MALIGNANCIES,"RETTIG, MICHAEL",WASHINGTON UNIVERSITY,MO,"$175,922"
Pediatric Cancer,2016,NCI,1R50CA211534-01,,Development of novel therapies for megakaryocytic malignancies,"WEN, QIANG",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$129,512"
Pediatric Cancer,2016,NCI,1K07CA211847-01,,Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer,"BONA, KIRA",DANA-FARBER CANCER INST,MA,"$133,475"
Pediatric Cancer,2016,NCI,1K08CA212299-01,,Molecular Interactions of APOBEC3 Enzymes with the Cancer Genome,"GREEN, ABBY",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$148,742"
Pediatric Cancer,2016,NCI,3R01CA175759-04S1,,Creating and Validating Child Adverse Event Reporting in Oncology Trials,"REEVE, BRYCE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$64,857"
Pediatric Cancer,2016,NICHD,1U54HD090215-01,8542,Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.,"RENBARGER, JAMIE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$278,802"
Pediatric Cancer,2016,NICHD,1U54HD090215-01,8543,Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation,"PACZESNY, SOPHIE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$255,554"
Pediatric Cancer,2016,NCI,1F99CA212487-01,,The role of Lin28/let 7 pathway in Wilms' tumor,"YERMALOVICH, ALENA",HARVARD UNIVERSITY,MA,"$33,026"
Pediatric Cancer,2016,NCI,1F99CA212489-01,,System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,"KIM , HUEN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$45,076"
Pediatric Cancer,2016,NCI,3P50CA171963-04S1,,Specialized Program Of Research Excellence (SPORE) in Leukemia,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$61,802"
Pediatric Cancer,2016,NCI,3R01CA166749-04S1,,The Role of Growth Factor Receptor Trafficking in Tumorigenesis,"ZAGE, PETER",BAYLOR COLLEGE OF MEDICINE,TX,"$13,734"
Pediatric Cancer,2016,NCI,3U01CA176063-03S1,,ARID5B and disparities of childhood leukemia,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$99,152"
Pediatric Cancer,2016,NINDS,1R01NS096899-01A1,,Regulation of Shh Signaling by Cellular Energetics,"CHIANG, CHIN",VANDERBILT UNIVERSITY,TN,"$396,407"
Pediatric Cancer,2016,NCI,3P30CA138292-08S1,,Winship Cancer Institute Cancer Center Support Grant,"CURRAN, WALTER",EMORY UNIVERSITY,GA,"$59,999"
Pediatric Cancer,2016,NIBIB,1R21EB022309-01A1,,Motion-Robust Methods for Rapid Pediatric MRI without Sedation,"MEYER, CRAIG",UNIVERSITY OF VIRGINIA,VA,"$188,570"
Pediatric Cancer,2016,NCI,6R21CA194829-02,,Metabolic regulation of T-ALL cellular proliferation and lifespan,"RATHMELL, JEFFREY",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$152,363"
Pediatric Cancer,2016,RMAP,1U24HD090744-01,,Characterizing pediatric genomes through an optimized sequencing approach,"LEVY, SHAWN",HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY,AL,"$6,300,000"
Pediatric Cancer,2016,NCI,1R41CA206859-01A1,,Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors,"DURDEN, DONALD","SIGNALRX PHARMACEUTICALS, INC.",CA,"$299,738"
Pediatric Cancer,2016,NINR,1F31NR016621-01A1,,Chronic Stress and Reproductive Function in Female Cancer Survivors,"HARDY, THERESA",MARQUETTE UNIVERSITY,WI,"$35,436"
Pediatric Cancer,2016,NCI,1F31CA206388-01A1,,Sensitizing Primary Bone Tumors to Radiation Therapy,"MAMO, TEWODROS",MAYO CLINIC ROCHESTER,MN,"$46,296"
Pediatric Cancer,2016,NCI,1R13CA213938-01,,Pediatric Hematology/Oncology Workforce Diversity and Healthcare Disparities,"MEIER, EMILY",INDIANA HEMOPHILIA & THROMBOSIS CENTER,IN,"$9,200"
Pediatric Cancer,2016,NCI,1F31CA213994-01,,"Three-dimensional, mechanically tunable scaffold systems to model osteosarcoma heterogeneity and therapeutic response","MOLINA, ERIC",RICE UNIVERSITY,TX,"$43,576"
Pediatric Cancer,2016,NCI,3U01CA176063-03S2,,ARID5B and disparities of childhood leukemia,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$199,999"
Pediatric Cancer,2016,NIDDK,6R01DK061470-13,,Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma,"CHUNG, DAI",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$409,278"
Pediatric Cancer,2016,NCI,7R21CA191751-03,,Repositioning Bazedoxifene as a novel IL-6/GP130 inhibitor for sarcoma therapy,"LIN, JIAYUH",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$198,398"
Pediatric Cancer,2016,NINDS,7R01NS087213-02,,A novel STAT3-selective inhibitor for medulloblastoma therapy,"LIN, JIAYUH",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$353,525"
Pediatric Cancer,2016,NCI,3P30CA013148-44S4,8603,04 Neuro-Oncology Program,"GILLESPIE, G.",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$8,694"
Pediatric Cancer,2016,NCI,3P30CA021765-37S2,,Cancer Center Support Grant Year 35 (CCSG),"ROBERTS, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$120,602"
Pediatric Cancer,2016,NCI,3U10CA180886-03S1,,COG NCTN Network Group Operations Center,"ADAMSON, PETER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$3,025,319"
Pediatric Cancer,2016,NCI,3R01CA151898-06A1S1,,CRLF2 signaling in B-cell acute lymphoblastic leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$199,999"
Pediatric Cancer,2016,NCI,4R00CA178191-03,,Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,"GURYANOVA, OLGA",UNIVERSITY OF FLORIDA,FL,"$252,971"
Pediatric Cancer,2016,NHLBI,1R56HL132921-01,,Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis,"NALEPA, GRZEGORZ",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$390,000"
Pediatric Cancer,2016,NCI,7R01CA182526-03,,Targeting Neuroblastoma with armed T cells,"LUM, LAWRENCE",UNIVERSITY OF VIRGINIA,VA,"$822,924"
Pediatric Cancer,2016,NCI,1ZIACP004410-40,,Family Studies,"TUCKER, MARGARET",NIH,,"$1,014,835"
Pediatric Cancer,2016,NCI,1ZIACP010122-21,,Occupational Exposure Assessment,"FRIESEN, MELISSA",NIH,,"$646,414"
Pediatric Cancer,2016,NCI,1ZIACP010125-21,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,788,656"
Pediatric Cancer,2016,NCI,1ZIACP010131-21,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"MORTON, LINDSAY",NIH,,"$3,331,177"
Pediatric Cancer,2016,NCI,1ZIACP010132-21,,Studies of Populations Exposed to Environmental Sources of Radiation,"BRENNER, ALINA",NIH,,"$2,428,038"
Pediatric Cancer,2016,NCI,1ZIACP010142-18,,Genetic Modifiers of Cancer Risk,"SAVAGE, SHARON",NIH,,"$517,754"
Pediatric Cancer,2016,NCI,1ZIACP010144-18,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"SAVAGE, SHARON",NIH,,"$9,672,204"
Pediatric Cancer,2016,NCI,1ZIACP010167-16,,General Studies of Epidemiology,"HOOVER, ROBERT",NIH,,"$188,507"
Pediatric Cancer,2016,NCI,1ZIACP010176-16,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$1,584,716"
Pediatric Cancer,2016,NCI,1ZIACP010219-06,,Studies of other risk factors for radiosensitive tumors,"KITAHARA, CARI",NIH,,"$438,440"
Pediatric Cancer,2016,NCI,1ZIACP010222-06,,Studies of Populations Exposed to Diagnostic Medical Radiation,"BERRINGTON, AMY",NIH,,"$813,765"
Pediatric Cancer,2016,NCI,4P01CA148600-06,5304,CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies,"DOTTI, GIANPIETRO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$46,051"
Pediatric Cancer,2016,NCI,1ZIABC004517-40,,DNA Repair in Human Cancer-Prone Genetic Diseases,"KRAEMER, KENNETH",NIH,,"$1,489,232"
Pediatric Cancer,2016,NCI,1ZIABC005093-38,,Growth-Differentiation Factors in Organogenesis,"PERANTONI, ALAN",NIH,,"$981,912"
Pediatric Cancer,2016,NCI,1ZIABC010008-21,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$415,450"
Pediatric Cancer,2016,NCI,1ZIABC010390-17,,Role of Neurotrophins in the Development of the Mammalian Nervous System,"TESSAROLLO, LINO",NIH,,"$743,429"
Pediatric Cancer,2016,NCI,1ZIABC010391-17,,Role of Trk Receptors in the Development and Function of Non-neuronal Structures,"TESSAROLLO, LINO",NIH,,"$725,297"
Pediatric Cancer,2016,NCI,1ZIABC010566-13,,Tumor and Metastasis Biology,"HELMAN, LEE",NIH,,"$173,792"
Pediatric Cancer,2016,NCI,1ZIABC010580-13,,Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"WARREN, KATHERINE",NIH,,"$13,322"
Pediatric Cancer,2016,NCI,1ZIABC010692-12,,Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,"ARTHUR, DIANE",NIH,,"$51,707"
Pediatric Cancer,2016,NCI,1ZIABC010701-11,,Human Monoclonal Antibodies Against Cancer,"DIMITROV, DIMITER",NIH,,"$909,717"
Pediatric Cancer,2016,NCI,1ZIABC010709-11,,Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,"WARREN, KATHERINE",NIH,,"$133,232"
Pediatric Cancer,2016,NCI,1ZIABC010759-11,,Functional Genomics of Sarcoma,"MELTZER, PAUL",NIH,,"$1,272,726"
Pediatric Cancer,2016,NCI,1ZIABC010788-10,,Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,"THIELE-GALETTO, CAROL",NIH,,"$871,159"
Pediatric Cancer,2016,NCI,1ZIABC010789-10,,Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,"THIELE-GALETTO, CAROL",NIH,,"$469,085"
Pediatric Cancer,2016,NCI,1ZIABC010801-10,,Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,"WIDEMANN, BRIGITTE",NIH,,"$1,005,422"
Pediatric Cancer,2016,NCI,1ZIABC010806-10,,Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,"KHAN, JAVED",NIH,,"$256,235"
Pediatric Cancer,2016,NCI,1ZIABC010870-09,,Hematopoietic Stem Cell Transplant for GATA2 Deficiency,"HICKSTEIN, DENNIS",NIH,,"$1,074,341"
Pediatric Cancer,2016,NCI,1ZIABC010871-09,,Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,"MERLINO, GLENN",NIH,,"$36,154"
Pediatric Cancer,2016,NCI,1ZIABC010959-09,,Relationship between DNA damage detection and signaling,"NUSSENZWEIG, ANDRE",NIH,,"$1,428,454"
Pediatric Cancer,2016,NCI,1ZIABC010998-09,,Identification of Novel Mutations In Pediatric Cancers,"KHAN, JAVED",NIH,,"$768,706"
Pediatric Cancer,2016,NCI,1ZIABC010999-09,,"Targeting FGFR4,  RAS, and  PAX3-FOXO1 gene in Rhabdomyosarcoma","KHAN, JAVED",NIH,,"$768,706"
Pediatric Cancer,2016,NCI,1ZIABC011002-09,,Bioinformatics: Systems Biology of Pediatric Cancers,"KHAN, JAVED",NIH,,"$512,471"
Pediatric Cancer,2016,NCI,1ZIABC011007-09,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$936,810"
Pediatric Cancer,2016,NCI,1ZIABC011070-09,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$964,476"
Pediatric Cancer,2016,NCI,1ZIABC011295-07,,ALL immunobiology and the bone marrow niche,"FRY, TERRY",NIH,,"$647,674"
Pediatric Cancer,2016,NCI,1ZIABC011298-07,,Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,"WARREN, KATHERINE",NIH,,"$66,615"
Pediatric Cancer,2016,NCI,1ZIABC011299-07,,Noninvasive Evaluation of Pediatric CNS Tumors,"WARREN, KATHERINE",NIH,,"$66,615"
Pediatric Cancer,2016,NCI,1ZIABC011328-07,,Characterization of the Osteosarcoma Genome,"MELTZER, PAUL",NIH,,"$1,357,574"
Pediatric Cancer,2016,NCI,1ZIABC011332-07,,Tumor Microenvironment in Cancer Progression,"KAPLAN, ROSANDRA",NIH,,"$515,673"
Pediatric Cancer,2016,NCI,1ZIABC011334-07,,Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,"KAPLAN, ROSANDRA",NIH,,"$515,673"
Pediatric Cancer,2016,NCI,1ZIABC011378-06,,Studies of amplification in rhabdomyosarcoma,"BARR, FREDERIC",NIH,,"$296,134"
Pediatric Cancer,2016,NCI,1ZIABC011387-06,,Studies of gene fusions in rhabdomyosarcoma,"BARR, FREDERIC",NIH,,"$592,267"
Pediatric Cancer,2016,NCI,1ZIABC011407-06,,Establishment of an International DIPG Registry,"WARREN, KATHERINE",NIH,,"$13,322"
Pediatric Cancer,2016,NCI,1ZIABC011423-05,,Epigenetic studies in rhabdomyosarcoma,"BARR, FREDERIC",NIH,,"$592,267"
Pediatric Cancer,2016,NCI,1ZIABC011447-05,,Early Clinical Trials for Children with CNS Tumors,"WARREN, KATHERINE",NIH,,"$399,695"
Pediatric Cancer,2016,NCI,1ZIABC011470-05,,Development of Natural Product Leads as Anticancer Therapeutics,"BEUTLER, JOHN",NIH,,"$408,562"
Pediatric Cancer,2016,NCI,1ZIABC011504-04,,Study the roles of p53 and p53 mutants in mesenchymal stem cells,"HUANG, JING",NIH,,"$595,344"
Pediatric Cancer,2016,NCI,1ZIABC011514-04,,Investigating Pediatric CNS tumor biology,"WARREN, KATHERINE",NIH,,"$133,232"
Pediatric Cancer,2016,NCI,1ZIABC011565-03,,Adoptive T cell Therapy for Pediatric Leukemia,"FRY, TERRY",NIH,,"$1,511,241"
Pediatric Cancer,2016,NCI,1ZIABC011643-02,,Rare Central Nervous System Cancers Initiative,"GILBERT, MARK",NIH,,"$393,294"
Pediatric Cancer,2016,NCI,1ZIABC011692-01,,COP Laboratory,"LEBLANC, AMY",NIH,,"$930,529"
Pediatric Cancer,2016,NCI,1ZIABC011704-01,,Discovery of genes required for expression or activity of fusion oncogenes,"CAPLEN, NATASHA",NIH,,"$1,643,939"
Pediatric Cancer,2016,NCI,1ZIABC011722-01,,Genomic characterization and development of therapies for Rhabdomyosarcoma,"SHERN, JOHN",NIH,,"$206,027"
Pediatric Cancer,2016,NCI,1ZIABC011734-01,,Genomic dissection of tumor heterogeneity and progression,"SHERN, JOHN",NIH,,"$206,027"
Pediatric Cancer,2016,NCI,1ZIASC006891-28,,Clinical Studies in Pediatric Solid Tumors,"HELMAN, LEE",NIH,,"$573,515"
Pediatric Cancer,2016,NCI,1ZIASC006892-28,,Molecular Biology of Pediatric Tumors,"HELMAN, LEE",NIH,,"$990,616"
Pediatric Cancer,2016,NCI,1ZIASC010354-17,,Clinical Development of Novel Drugs for Children with Refractory Cancers,"WIDEMANN, BRIGITTE",NIH,,"$670,281"
Pediatric Cancer,2016,NCI,1ZIASC010366-16,,Identification of Genes for Predicting Prognosis in Pediatric Cancers,"KHAN, JAVED",NIH,,"$256,235"
Pediatric Cancer,2016,NCI,1ZIASC010378-16,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$469,870"
Pediatric Cancer,2016,NCI,1ZIASC010384-16,,Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"HICKSTEIN, DENNIS",NIH,,"$322,303"
Pediatric Cancer,2016,NCI,1ZICBC011040-09,,Molecular Profiling of Clinical Specimens,"EDELMAN, DANIEL",NIH,,"$3,128,081"
Pediatric Cancer,2016,NCI,1ZICBC011048-09,,Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma,"CAO, LIANG",NIH,,"$84,167"
Pediatric Cancer,2016,NCI,1ZICBC011079-09,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$1,793,683"
Pediatric Cancer,2016,NCI,1ZIDBC010990-09,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$7,464,425"
Pediatric Cancer,2016,NCI,1ZIDBC011517-04,,Pediatric Oncology Branch Behavioral Science Core,"GLOD, JOHN",NIH,,"$1,218,420"
Pediatric Cancer,2016,NCI,1ZIDBC011729-01,,Chronic graft-versus-host disease in children and young adults,"BUXBAUM, NATALIYA",NIH,,"$49,557"
Pediatric Cancer,2016,NCI,1ZIEBC011516-04,,Pediatric Oncology Branch Clinical Care and Education,"GLOD, JOHN",NIH,,"$4,873,680"
Pediatric Cancer,2016,NIA,1ZIAAG000661-14,,Characterization of a Complex Involved In Rothmund-Thomson Syndrome,"WANG, WEIDONG",NIH,,"$589,524"
Pediatric Cancer,2016,NCI,7F30CA186632-04,,Exploring the role of Mediator in oncogenic transcription,"BHAGWAT, ANAND",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$27,576"
Pediatric Cancer,2016,NHLBI,1ZIAHL002315-34,,Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments,"YOUNG, NEAL",NIH,,"$3,187,485"
Pediatric Cancer,2016,NHLBI,1ZIAHL006106-06,,Immunobiology and immunotherapy of leukemia,"BARRETT, AUSTIN",NIH,,"$1,074,460"
Pediatric Cancer,2016,NIAID,1ZIAAI000732-22,,"Clinical, Immunological and Genetic  Analyses of ALPS and Related Disordrs","RAO, VEMULKONDA",NIH,,"$273,477"
Pediatric Cancer,2016,NCATS,1ZIATR000044-02,,The development of multikinase inhibitors for the treatment of selected cancers,"THOMAS, CRAIG",NIH,,"$166,843"
Pediatric Cancer,2016,NINDS,1ZIANS003051-09,,Central Nervous System Drug Delivery Techniques,"YOULE, RICHARD",NIH,,"$608,785"
Pediatric Cancer,2016,NINDS,1ZIANS003052-09,,Molecular Pathogenesis of Neoplasia,"YOULE, RICHARD",NIH,,"$1,014,642"
Pediatric Cancer,2016,NINDS,1ZIANS003053-09,,Neuro-oncology of Familial Neoplasia Syndromes,"YOULE, RICHARD",NIH,,"$811,713"
Pediatric Cancer,2016,NINDS,1ZIANS003132-05,,Neurooncology of Benign Central and Peripheral Nervous System Tumors,"HEISS, JOHN",NIH,,"$811,713"
Pediatric Cancer,2016,NHGRI,1ZIAHG000030-22,,Mechanistic and translational studies of CBF leukemia,"LIU, PAUL",NIH,,"$1,003,899"
Pediatric Cancer,2016,NCATS,1ZIATR000157-02,,Phenotypic Toxicity Screening in FAK/Ewings Sarcoma,"SHEN, MIN",NIH,,"$121,984"
Pediatric Cancer,2016,NCATS,1ZIATR000059-02,,Drug Repurposing in Pediatric Oncology,"JADHAV, AJIT",NIH,,"$37,474"
